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ABSTRACT 
Xanthomonas campestris pathovar musacearum (Xcm) is the causal agent of 
Xanthomonas Wilt (XW) of Bananas. It is currently the greatest threat to the existence 
and production of bananas in Uganda and other neighboring countries. XW on banana 
is able to cause about 80-100% field losses. There are currently no known chemicals, 
herbicides or resistant banana cultivars that can be used to control this disease. 
Despite awareness efforts among farmers, this disease continues to bring down the 
yield of bananas in growing areas. This is also due to the fact that symptoms caused by 
XW are similar to, and often indistinguishable from those caused by manageable 
common banana diseases such as Fusarium wilt. The key control strategy of XW is 
immediate destruction of infected plants. There is therefore need for early and accurate 
detection of Xcm: an onsite field detection tool. There are currently PCR (polymerase 
chain reaction) laboratory based assays and antibody based systems that are used for 
detection of this bacterium.  This study developed another antibody-based system: an 
ELISA polyclonal antibody assay for Xcm formatted in to a lateral flow device (LFD). 
This study also introduces a new pathovar, Xanthomonas vasicola pv musacearum, to 
the species Xanthomonas vasicola and therefore carried out large scale comparative 
pathogenicity testing of the X.vasicola pathovars on maize, banana and sugarcane. 
This study further characterized a new collection of Xcm isolates from Western Uganda 
to determine their genotypes based on a subset of the 86 Single Nucleotide 
Polymorphisms that divided Xcm isolates into two major sub- lineages (I&II)  as 
previously reported (Wasukira et al, 2012).  
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1. INTRODUCTION 
Importance of bananas in East Africa 
Bananas are considered to be the most important staple food in Uganda.  Meeting both 
subsistence and commercial purposes, over 75% of Ugandan farmers cultivate banana 
on an estimated 1M hectares of the land (FAO, 2010) making Uganda the world’s 
second largest producer of bananas after India (Triptathi et al, 2009). At the regional 
level, the Great Lakes region, covering Uganda, Rwanda, Burundi, Tanzania, Kenya 
and The Democratic Republic of Congo (DRC), is the largest producer and consumer of 
banana in Africa (Smale, 2006) with a per capita consumption per year estimated at 
more than 250kg; the highest in the world.  In Africa banana provides more than 25% of 
the carbohydrate requirements for over 70 million people (IITA, 1998).  
 
Both green and table bananas are marketed for food and the crop residues also provide 
fodder for zero- grazed animals, which in turn provide manure for the farm for the 
agronomic health of the crop (Spilsbury et al, 2002, Komarek et al, 2010). Apart from 
mixed farming, the plant is readily inter-cropped with both perennial and annual crops, 
especially legumes thus contributing to a balanced diet for producers (Karamura et al, 
1998).This large plant also reduces soil erosion through driving rain and sheet erosion, 
by acting as a wind break, especially in highland agro-ecologies.  In the urban regions, 
the manufacture of banana fiber based handicrafts such as mats, baskets, lamp sheds, 
ropes plus a host of decorations has become an important economic activity.  
 
However, for the past two decades, the steady  production of bananas in Uganda and 
East Africa as a whole has experienced a number of constraints that have affected 
productivity (yield) and relative preference in cultivation to other crops (Anon, 2007). 
The major constraints to the production of this major food crop include low soil fertility, 
pests such as weevils, nematodes and diseases; Black Sigatoka, Banana leaf streak 
disease and Fusarium wilt. Xanthomonas wilt (XW) of Bananas otherwise refered to as 
Banana Xanthomonas wilt is the greatest threat to existence of bananas in Uganda.  
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Up until the discovery of XW, farmers have been able to control all other biotic threats 
(nematodes, weevils) through cultural practices exploiting differences in cultivar 
resistances and tolerance. In this way farmers suffered reduced productivity, but 
maintained reasonable levels of food and income security. However, following the 
arrival of XW in Uganda, farmers have suffered close to 80-100% field losses. 
 
XW is caused by a bacterium called Xanthomonas campestris pathovar (pv) 
musacearum (Xcm). Xanthomonas wilt (XW) was first discovered in Central Uganda in 
2001 (Tushemereirwe et al, 2004) and subsequently spread to Republic of Congo 
(Ndungo et al, 2006), Rwanda (Reeder et al, 2007) and Kenya, Tanzania and Burundi 
(Carter et al, 2010). Prior to this discovery, the disease was only known in Ethiopia on 
enset plants (Ensete ventricosum) (Yirgou et al, 1968 & Bradbury et al,1974).The 
pathogen destroys banana plants (Musa species), resulting in total loss of production 
and threatening the livelihoods of millions of people who depend on bananas as a food 
and income source in the region. There is therefore need for control and containment of 
Xcm, but most especially an onsite field diagnostic tool to detect the bacteria. 
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2. LITERATURE REVIEW AND BACKGROUND 
2.1 Taxonomy of Bananas 
Bananas are monocots that belong to the order of Zingiberales and the family of 
Musaceae. Members of this family are large plants 2-9 meters tall with an aerial trunk 
consisting of compacted leaf sheaths which grow directly from the top of the corm. 
Musaceae contains two genera: Musa (Simmonds, 1966) and Ensete (Cobley, 1976). 
Genus Ensete is distributed wildly in Africa from the Cameroon throughout East Africa 
down to the Transvaal in South Africa (Karamura, 1998). Ensete differs from Musa by 
being monocarpic, non-suckering with a distinctively swollen base, and having large-
sized seeds while Musa produces suckers and has small seeds (Cobley, 1976); 
(Samson, 1992). 
 
The genus Musa contains 30-40 species and all wild species are diploids (2n=2x=14, 
18) while the cultivated/domesticated species are polyploid. Genus Musa is divided into 
5 sections, based mainly on the basic chromosome number, orientation and 
arrangement of flowers in the inflorescences. The sections are Musa, Rhodochlamps, 
Callimisa, Australimusa and Ingentimusa. The section Musa is the largest with 13-15 
species, the most diversified and most ancient (Karamura, 1998). The sections include 
cooking bananas, dessert bananas and plantains now grown throughout the tropics. 
The wild species of Musa can reproduce both sexually and asexually (by suckers from 
a corm). Among the fifteen wild species are the Musa acuminata Colla and Musa 
balbisiana Colla, both of which have contributed to the origin of the majority of edible 
bananas (Purseglove, 1972); (Simmonds, 1987). 
 
2.2 Banana morphology 
Bananas are perennial giant plants that grow from an offshoot growing at the base of 
the plant (the sucker or the corm), that replaces the mother plant. The corm produces 
aerial roots which arise from the lateral buds which develop into eyes and later suckers. 
The continuous vegetative growth of the suckers perpetuates the corm’s life and hence 
the perennial status of bananas. The mat, also called stool, is the term used to 
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designate the mother plant and its suckers. The tightly packed foliage forms the 
pseudo-stem or the aerial shoot (Anon, 2007). The corm also includes the apical 
meristem from which the leaves and ultimately the flowers are initiated. When the 
banana plant has formed an average of 40 leaves(within 8 to 18 months), the terminal 
bud of the corm develops directly into the inflorescence which is carried up on a long 
smooth un-branched stem through the centre of the pseudo-stem emerging at the top in 
the centre of the leaf cluster (Anon, 2007). 
 
The inflorescence consists of male and female flowers arranged in a group. The female 
inflorescences develop into fingers that constitute the bunch. Banana bunches posses 
up to 14 hands (clusters), each with up to 10 fingers which varies from cultivar to 
cultivar. Most cultivated bananas lack pollen while the wild bananas are able to produce 
both nectar and pollen (Anon, 2007). 
 
2.3 Evolution and introduction of bananas to Africa 
Unreduced gamete production at the end of meiosis in diploid edible M.acuminata 
introduced the AAA (acuminata) triploids which by virtue of being more vigorous and for 
producing bigger fruits (Karamura, 1998), now dominate the world’s bananas. There is 
no clear evidence as to what led to the evolution of edible bananas especially due to 
wide variability of M. Acuminata. There are no natural edible forms of diploid BB Musa 
balbisiana or triploids BBB of this species. 
 
 Another important step in the evolution of bananas was the crossing of AA (and 
perhaps AAA too) cultivated bananas with the wild M. balbisiana (BB). Natural 
hybridization occurred in several genome combinations and the resulting hybrids were 
AB, AAB and ABB. At present, there are many clones of cultivated bananas belonging 
to different genome groups, of which AA, AAA, AAB and ABB are the most numerous 
(Karamura, 1998). 
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2.4 Banana production and its value in Uganda 
2.4.1 Banana cultivars in Uganda 
Most of the bananas grown in Uganda are East African bananas. East African bananas 
are categorized in three groups; dessert bananas (AAA), plantains (AAB) and the East 
African Highland (AAA-EAHB, cooking and beer) bananas (Karamura, 1998). However 
the East African Highland bananas (AAA) that grow between 1200 and 1900 meters 
above sea level are the most widely distributed. Bananas are of diverse types according 
to end uses: cooking, roasting, dessert and beer bananas. This has been used to group 
banana varieties - on the basis of their end uses (Karamura, 1998). 
 
2.4.2 Production of banana in Uganda 
Bananas are the single most important staple food in Uganda. Uganda ranks second 
after India in the world banana production with an annual output of 10 million tonnes 
(FAO, 2010), accounting for more than 11.18% of the world’s total production. 
 
The crop has been grown for both commercial and subsistence purposes. Apart from 
being a key staple food, bananas are increasingly becoming an important source of 
income for the poor farmers. Excess production is sold in local markets and is the main 
staple food for urban workers (Karamura, 1998). The bananas in Uganda fall into three 
categories; cooking bananas which are boiled and eaten, the beer bananas from which 
juice can be made and the plantains that can be steamed, fried or roasted. Beer 
production from bananas in Uganda is also on the increase. 
 
Bananas have also become an important component of mixed production systems on 
farms especially in high population areas where land is limited. Here bananas provide 
fodder for zero-grazed animals, which in turn provide manure for the farm. Apart from 
mixed farming, the plant is readily inter-cropped with both perennial and annual crops, 
especially legumes such as beans thus contributing to a balanced diet for producers 
(Karamura, 1998). From the dry leaves of the pseudo-stem, mats, lamp shades, ropes 
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and crafts can be made. Bananas are also used for medicinal purposes to treat 
abdominal ailments such as ulcers. 
 
 
 
Figure 1: Comparison of VPCs (Vegetative Crops by production) of Eastern Africa 
(FAO Crop Production data, 2009; Listed East African countries only, excluding 
non-mainland countries) 
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2.4.3 Production constraints of Bananas in Uganda 
Several factors contribute to the decline of production yields of this important crop. 
 
According to a brief by IFPRI (2005) in terms of associated yield losses and year of 
plantation cycle, the emerging XW on banana contributes to 80-100% loss in the first 
year, Black Sigatoka causes about 30-50% in the third year, low soil fertility contributes 
to about 10-70% loss in the third or fourth year, nematodes cause about 40-60% loss in 
the fourth year. This makes XW the biggest threat to the production yields of bananas in 
Uganda.   However these constraints do the most damage in already low productivity 
areas than the high productivity areas. 
 
According to the 2010 FAO statistics report, banana production in Uganda dropped by 
at least 500,000 tonnes between the years of 2005 and 2008, 3 years after the first 
report of XW in 2001. Probably with more awareness of XW among farmers, the 
production of bananas began to increase after 2009 (see Figure 1). The production of 
cassava, which is the second most grown crop (next to banana) in Uganda, increased 
after 2001 (since the first report of XW) by about 1,000,000 tonnes compared to the 
previous years before 2001. This suggests that farmers began to put in more effort in to 
cropping cassava to combat food losses caused by Xanthomonas wilt of bananas. 
 
2.5 Major Banana pests and diseases in Uganda 
2.5.1 Fusarium wilt (Panama wilt) 
This is caused by a soil-borne fungus, Fusarium oxysporum f.sp. cubense.  This is also 
known to be among the most destructive diseases and can cause about 100% loss if 
not controlled (Anon et al, 2001). It is a typical vascular disease that causes disruption 
of translocation and systemic foliage which may lead to the collapse of the pseudo-
stem. Fusarium wilt attacks the ABB genome banana cultivars but the indigenous East 
African Highland AAA cultivars and Cavendish cultivars seem resistant to the disease 
(Mwangi et al, 2007). Fusarium wilt tends to cause similar symptoms as those caused 
by Banana Xanthomonas Wilt, making it difficult for farmers to manage Fusarium wilt. 
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Symptoms of the disease include yellowing of leaves or premature collapse of the 
leaves (begins with the older leaves), and discoloured vascular bundles when you cut 
up the pseudo-stem. If the disease is severe, the banana plant may fail to produce 
flowers or bunches (Anon et al, 2001). The disease spreads through already infected 
plant materials, soils and tools with Fusarium propagules. 
 
2.5.1a Control of Fusarium wilt 
Use of resistant cultivars: Not much can be done once the plant is attacked by 
Fusarium wilt therefore farmers are encouraged to grow the resistant cultivars such as 
the Cavendish bananas, banana hybrids likes FHIA 17 and FHIA 23(most banana 
hybrids are tetraploids AAAB or AAAA). If susceptible cultivars are to be planted, it is 
important that soils are Fusarium free; in some cases soil fumigation can be done 
(Mwangi et al, 2007). 
 
Use of clean planting materials: To be able to use clean banana planting materials, 
farmers are encouraged to source free tissue culture plantlets (macro-propagation) from 
the National Agriculture Research Laboratories (Anon et al, 2001).  
 
2.5.2 Black Sigatoka 
This disease is also known as Black Streak Leaf disease and is caused by a fungus, 
Mycosphaerella fijiensis. The disease reduces and destroys leaves of the banana plant. 
The leaf necrosis reduces fruit yield of the plant. The disease is also characterized by 
the appearance of brown spots on the leaf which later enlarge to form black patches 
which later develop spots with grey centers (Anon et al, 2001). High humidity favors the 
growth of the fungus ad water helps in the spread of its spores to infect other plants. 
 
2.5.2a Control of Black Sigatoka 
Cultural practices: Farmers have resorted to cutting off infected leaves of the 
bananas. This prevents easy spread of the fungus. However this can also lead to the 
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spread of the disease by continual use of the cutting tools, hence sterilization of the 
tools is also encouraged. 
 
Good crop husbandry: Proper crop spacing, continuous weeding and good drainage 
in the fields would help reduce the humidity that would favor the growth of the fungus. 
 
Use of resistant cultivars: This is the most effective method of controlling this 
disease. However, most of the highland bananas are  susceptible to the disease.  Most 
banana hybrids such as FHIA 1, FHIA 3, FHIA 17 and FHIA 23 have been proven to be 
resistant to Black Sigatoka (Anon et al, 2001). 
 
2.5.3 Banana Streak virus 
This disease is caused by a plant pararetrovirus belonging to the family of 
Caulimoviridae. Symptoms include; leaves initially have yellow streaks which later turn 
to golden necrotic streaks, the plant may have stunted growth and produce smaller 
bunches or distorted fruits.  Symptom expression is temperature dependent and the 
effect on yield depends on whether flowering and bunch initiation coincide with 
temperatures that increase virus replication within the plant (Mwangi et al, 2007). 
Spread of the virus is still undetermined. 
 
2.5.3a Control of Banana Streak virus 
Use of clean planting materials: Farmers are encouraged to completely destroy 
already diseased plants and ensure that only healthy suckers (from macro-propagation) 
are re-planted. 
  
2.5.4 Xanthomonas Wilt (XW) on Banana 
The disease is caused by a bacterium Xanthomonas campestris pv musacearum. It 
was first reported in Ethiopia causing Ensete Bacterial wilt in Ensete plants by Yirgou 
and Bradbury in 1968. It then spread to Uganda and was first reported in 2001. It is 
emerging as the most deadly disease of bananas. It causes close to 80-100% field 
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losses. It attacks both young and mature plants and at its advanced stages, the 
pseudo-stem collapses. Its symptoms are quite similar to those of Fusarium wilt and 
Moko disease. This is the most serious disease that farmers have not been able to 
control and worse still, there are no known resistant cultivars.  
 
XW will be discussed in more details in subsequent sections. 
 
2.5.5 Banana weevils 
The most common of the weevil is the species Cosmopolites sordidus. Weevil damage 
results from larvae (usually from an egg that has been laid near the corm by an adult 
weevil) that feeds and tunnels through the banana corm and pseudo-stems (Mwangi et 
al, 2007). This causes galleries that weaken the plant and provide entry points for ants 
and other pests (such as the bacterium Xanthomonas campestris pv musacearum) and 
this eventually leads to plants toppling after snapping at the base (Mwangi et al, 2007). 
The damage also affects the uptake of nutrients and water thus weakening the plant. 
The East African Highland bananas are not easily affected as the weevil prefers lower 
altitudes about 1000-1200 meters above sea level than the high altitudes of 1500m or 
more (Anon et al, 2001). 
 
2.5.5a Control of the weevil 
Use of clean planting materials: Only corms that do not bear symptoms of weevil 
damage should be planted. Corms should be peeled to expose the white tissue to look 
for signs of tunneling by the weevils. To be sure that the corms are clean, they should 
be subjected to hot water or chemical dipping (dursban) to kill any larvae (Anon et al, 
2001). 
 
Field sanitation: Proper weeding and sucker removal can reduce the niches of the 
weevils. Discarded corms should be chopped up and destroyed to reduce weevil 
breeding. 
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Chemical control: Chemical insecticides can be spread around the banana plants 
close to the corms to kill weevils. In Uganda, chemicals such as Furadan, Primicid and 
Dursban are used (Anon et al, 2001). 
 
Other potential control methods: Use of resistant cultivars could also be a solution to 
crop loss by weevils. Two East African Highland banana hybrids M2 and M9 bananas 
are known to be resistant to weevils (Tinzaara et al, 2009). 
 
2.5.6 Nematodes 
Nematodes are small worms that cannot be seen with the naked eye. They parasitize 
the banana root system and can reduce yield by up to 80%.  A root corm damaged by 
nematodes shows reddish brown lesions or necrosis when split or peeled. This results 
in lower nutrient uptake and increases plant toppling. The most widespread nematodes 
include Radopholus similis, Pratylenchus goodeyi, Pratylenchus coffeae, 
Helicotylenchus multicinctus and Meloidogyne spp. The nematode R. similis contributes 
to most plant toppling (Mwangi et al, 2007). 
 
2.5.6a Control of nematodes 
Use of clean planting material: Nematodes like weevils can be avoided by planting 
clean planting materials.  Nematodes have limited mobility so most are spread by 
infected plant material (Tinzaara et al, 2009). Corms must be checked for signs of 
nematode damage. To ensure that clean material is planted, the corms must be dipped 
in hot water (Anon et al, 2001). 
 
Good crop husbandry: Crop rotation of bananas with plants that are not affected by 
nematodes is also a good way to control nematodes (Tinzaara et al, 2009). 
 
Chemical control: Use of nematicides can also be used to eliminate nematodes. They 
should be spread around the banana corms. The chemical commonly used is Furadan 
(carbofuran; Anon et al, 2001). 
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2.6 Classification of Xanthomonas campestris pv musacearum  
2.6.1 Genus Xanthomonas 
Xanthomonas is a genus of the class Gamma-proteobacteria under the order of 
Xanthomonadales under family of Xanthomonadaceae. They are Gram-negative 
bacteria, aerobic and motile by a single polar flagellum. The cells are single, straight 
rods usually within the range of 0.4 - 0.7um wide and 0.7 - 1.8um long. Most form 
yellow colonies and are usually chemoorganotrophs.  The yellow pigments are mono-
dibromo arylpolyenes called xanthomonadins, which are characteristic of the genus 
(Vauterin et al, 1995). The optimum temperature for growth is about 25-30 ◦C. Most 
Xanthomonas are significant plant-pathogens that cause severe crop disease and 
death. Xanthomonas consists of many species.  
 
The classification and taxonomy of Xanthomonas has long been based on phenotypic 
features and host specificity. It was common practice to define a plant-pathogenic 
Xanthomonad isolated from a new host plant as a new Xanthomonas species (Vauterin 
et al, 1995). This ‘new host-new species’ method increased the number of species 
within the genus. Later, almost all the Xanthomonas species were merged into the one 
species X. campestris by Dye et al, (1962) as there was not enough information at the 
time to classify the species in the genus (Vauterin et al, 2000). Young et al (1978) then 
proposed reclassifying the species into pathovars, based on their pathogenicity, and 
this is the system that is still in use (Vauterin et al, 2000). Pathovars are defined by one 
single feature; distinct pathogenicity on one or more hosts. However, with advances in 
molecular typing (such as DNA-DNA hybridization or RAPD analysis) methods, it has 
been noted that most of the former X. campestris species or species that had originally 
been placed in X. campestris are indeed heterogeneous. Currently, Xanthomonas has 
over 140 pathovars (Vauterin et al, 2000). 
 
Plant pathologists are still trying to find ways of classifying Xanthomonas as this will be 
helpful in combating and controlling the plant diseases they cause. The pathovar 
classification system that is still in use has limitations; “the host range of most 
pathogenic Xanthomonas species is still unknown, there is significant heterogeneity 
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within a number of pathovars and this system leaves out non-pathogenic Xanthomonas” 
(Vauterin et al, 2000). 
 
Xanthomonas species have been grouped/classified using a number of techniques. 
These include: comparison of B gyrase sequences within Xanthomonas strains 
(Parkinson et al, 2009), Rep-PCR genomic fingerprinting of Xanthomonas strains 
Rademaker et al, 2005) and DNA-DNA hybridization technique (Vauterin et al, 2000). 
 
The genus seems to comprise  20 or more DNA homology groups of species; X. 
fragariae, X. hortorum, X. populi, X. arboricola, X. cassavae, X. codiaei, X. bromi, X. 
cucurbitae, X. axonopodis, X. oryzae, X. vasicola, X. pisi, X. melonis, X. vesicatoria, X. 
campestris, X. translucens, X. hyacinthi, X. theicola, X. sacchari and X. albilineans 
(Vauterin et al, 2000). Xanthomonas campestris pv musacearum strains have until very 
recently not been included in studies on taxonomy. 
 
Plant pathologists are still trying to find ways of improving the classification of 
Xanthomonas as this will be helpful in combating and controlling the plant diseases they 
cause. Indeed, the pathovar classification system has limitations. 
 
2.6.2 Classification of Xanthomonas campestris pv musacearum  
Recent studies  on comparison of B gyrase sequences of Xanthomonas strains that 
included Xanthomonas campestris pv musacearum (Xcm)  showed that the strains fall 
in the same homology (share genetic similarities) group as Xanthomonas vasicola (X. 
vasicola) strains ( Parkinson et al, 2009). The X. vasicola pathovars are the proposed X 
vasicola pv holcicola (Xvh) and X vasicola pv vasculorum (Xvv)(Vauterin et al, 1995) 
commonly pathogenic on sorghum and sugarcane respectively. However the 
reclassification of Xvv was considered incomplete in terms of standards for naming 
pathovars and in turn this invalidated the name of Xvh and reducing the pathovar to X. 
vasicola species (Garrity, 2005). It should therefore be noted that Xvv and Xvh are still 
proposed names. 
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However FAME analysis (whole bacteria cell fatty acids converted to methyl esters and 
analyzed by gas chromatography), Rep-PCR (PCR with primers complementary to 
naturally occurring conserved repetitive DNA elements within a bacteria genome) and B 
gyrase sequence studies done on the Xcm strains showed that they are actually more 
closely related or genetically similar to strains that commonly attack sugarcane( Xvv 
Aritua et al, 2008; Parkinson et al, 2009). Pathogenicity tests done in the same study 
revealed that Xcm can cause disease in maize and banana but the X. vasicola strains 
could only cause disease in maize and not in banana. This may suggest that some X. 
vasicola strains, ‘Xvv’ in particular may have evolved to include banana as a host as 
they are able to retain pathogenicity in maize and sugarcane.   
 
Aritua et al, (2008) therefore proposed that Xcm be renamed Xanthomonas vasicola pv 
musacearum. However comparative pathogenicity studies of the Xanthomonas vasicola 
pathovars has not been done (Garrity, 2005) so the proposal of renaming Xcm could 
not be supported. Xanthomonas campestris pv musacearum strains did not show much 
genetic similarity when compared to other Xanthomonas campestris pathovars. This is 
not surprising considering that DNA-DNA homology studies have placed many former 
Xanthomonas campestris species into new other species (Vauterin et al, 1995). When 
Xanthomonas campestris pv musacearum was discovered in 1968 by Yirgou and 
Bradbury (Yirgou et al, 1968), it was first placed under the Xanthomonas musacearum 
species.  
 
2.6.3 Variation within the isolates of Xanthomonas campestris pv musacearum 
Initial studies on Xcm strains were based on rep-PCR and showed very limited genetic 
diversity (Aritua et al, 2007, 2008; Odipo et al, 2009).  Yet with genome wide 
sequencing, recent studies have shown that there may be two major sub–lineages of 
the pathogen based on consistent single-nucleotide polymorphisms (SNPs) among the 
East African isolates (Wasukira et al, 2012). This study revealed that Xcm isolates from 
Uganda, Kenya, Tanzania and Burundi (lineage I) are distinct from isolates from 
Ethiopia, DR Congo and Rwanda (lineage II) based on 86 polymorphic positions.  
Based on the sequence of the SNPs, primers flanking SNPs that code for enzyme 
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restriction sites have been designed to allow the two sub-lineages to be resolved by 
PCR and restriction analysis.  However, it was observed that of the two Ethiopian 
strains (NCPPB 2005 & NCPPB 2251) included in the study these share some 
similarities with both lineages.  As yet the robustness of the lineages has not been 
established sufficiently and will require study of a more extensive collection of Xcm 
strain from across the region and especially Ethiopia.   
 
As the first reports of XW were from Ethiopia on enset and Musa plants and then in 
Uganda on banana, it has been widely assumed that the origin of the pathogen into 
Uganda was from Ethiopia and probably as a single event.  These findings have 
provided some challenges to this assumption. 
 
2.6.4 State of current knowledge on Xanthomonas campestris pv musacearum 
and Xanthomonas vasicola pv vasculorum strains 
Draft genomes of Xanthomonas campestris pv musacearum and Xanthomonas 
vasicola pv vasculorum have since been generated by Studholme et al, (2010). This 
study showed that both genomes are highly similar with a few differences.  However 
one of the most striking differences is the difference in the repertoires of their T3SS 
virulence effectors. T3SS virulence system in bacteria is responsible for colonizing and 
parasitizing susceptible plant hosts by use of translocation of effectors into the plant 
(Bretz et al, 2004).The effectors, once in the plant, target host defensive cells and 
cause virulence. However plants  have the R  genes that can recognize these effectors 
thereby eliciting defense responses. Disease in a plant happens when the R genes of 
the plant do not recognize these effectors. 
 
Xcm strains have the YopJ-like C55 cysteine proteases in its T3SS apparatus thought 
to be able to suppress the defenses of banana while Xvv has the AvrXv3 thought to 
cause avirulence in banana but the R gene in banana is able to recognize it (Studholme 
et al, 2010). Accordingly, it has been speculated that the differences in the T3SS 
effectors between Xcm and Xvv strains may be responsible for the differences in host 
adaptation (Studholme et al, 2010).  
36 
2.7 Xanthomonas Wilt of Bananas (Banana Xanthomonas Wilt) 
Xanthomonas campestris pv musacearum, the etiological agent of Xanthomonas wilt of 
bananas was first reported in Ethiopia in 1968 by Yirgou and Bradbury. It attacks 
Ensete (Ensete ventricosum) plants that are within the same family with banana plants 
(Musa spp). It was first reported affecting bananas within Mukono district in Uganda in 
2001 (Tushemereirwe et al, 2004). Its symptoms strongly resembled those of Moko 
disease, a common disease of bananas in Asia, caused by the bacterium Ralstonia 
solanacearum. However after pathogenicity tests were done on healthy plants, the 
bacterium was confirmed to be Xanthomonas campestris pv musacearum as 
referenced from literature (Yirgou et al, 1968). Later the disease spread to the 
neighboring countries of Democratic Republic of Republic of Congo (Ndungo et al, 
2006), Rwanda (Reeder et al, 2007) and Kenya, Tanzania and Burundi (Carter et al, 
2010). 
 
2.7.1 Diagnosis of Xanthomonas Wilt 
Symptoms of Xanthomonas wilt on infected banana plants include premature ripening 
of the fruit, shriveling of male buds, progressive yellowing and wilting of leaves and 
when the pseudo stem is cut, pockets of yellow bacterial ooze are seen after 15 to 20 
minutes, this usually confirms the presence of the disease (Tinzaara et al, 2006). 
Symptoms on floral parts include wilting of bracts, shriveling and rotting of male buds, 
and yellow–brown flower stalks (Tripathi et al, 2009a). Yellow or brown streaks also 
occur in the vascular tissues of the infected plants. According to Yirgou and Bradbury 
(1968, 1974), the first symptom of the leaf was the dull green colour of the lamina, 
which gradually becomes scalded in appearance and folds back on the midrib with the 
two halves of the leaves touching each other. The scalded leaf eventually withers and 
the whole plant rots. 
 
2.7.2 Spread and transmission 
Xanthomonas campestris pv musacearum can be spread through planting already 
infected plant materials and plant parts and use of contaminated cutting tools 
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(Karamura et al, 2010). The disease can also be spread through contaminated soil, and 
traded banana products (seedlings, fruits, leaves, and fibers (Tripathi et al, 2009a)). 
 
Epidemiological studies have shown that the bacteria may also be carried by insect 
vectors from infected plants to the male buds of disease-free plants within and between 
farms (Tinzaara et al, 2006). This is in fact is believed to be the primary means of 
spread. Insects carrying the bacteria will frequently visit the floral parts. Insects that visit 
the flowers include bumblebees, stingless bees, wasps, hover flies, ants, fruit flies and 
cockroaches (Tinzaara et al, 2006). This correlates with the fact that the first initial 
symptoms of the disease are usually seen on the male bud (Tushemereirwe et al, 
2003). Long distance spread of the pathogen is suspected to take place through the 
transport of rhizomes/suckers that are already infected (Tinzaara et al, 2006). 
 
2.7.3 Disease host range, distribution and damage 
Other than bananas, Xanthomonas campestris pv musacearum also attacks Ensete 
ventricosum plants, that belong to the same botanical family as bananas. Host range 
studies have shown that Xcm infect plant families like Musaceae and Cannaceae. Other 
studies also showed maize to be potential hosts (Aritua et al, 2008). Ssekiwoko et al 
(2006) concluded that Xcm does perhaps restrict its host range to monocots. 
 
Studies were taken to assess the impact of XW on banana production in Uganda 
between the years of 2001- 2004. In 2001 (first report of XW in Uganda), areas that had 
been affected by XW produced relatively similar amount of banana bunches with areas 
that had not been affected (Karamura et al, 2010). But in 2004, the areas that had not 
been affected by XW produced twice as much as bunches of banana compared to the 
areas that had previously been hit by XW. The production of bananas among the 
affected house-holds fell had fallen close to 52% or about 10-17% per annum between 
the years of 2001-2004 (Karamura et al, 2010). 
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2.7.4 Control measures/strategies for Xanthomonas Wilt of Banana 
Strategies have been put in place to combat XW of bananas. Most of the control 
practices are based on the specific control practices of controlling Moko disease. Moko 
disease or Bacterial wilt  attacks bananas in South East Asia and is caused by  the 
bacterium Ralstonia solanacearum. 
 
2.7.4a Cultural practices 
Destruction of infected plants/plant material: Once identified, all infected plants or 
plant materials are either totally uprooted and destroyed or buried. This has been a key 
control method to stop the spread of the bacteria. However cultural perceptions of the 
banana plant by people in Uganda make such recommendations of banana mat 
destruction not easily considered or acceptable (Smith et al, 2007). Currently it is 
recommended that at least 6 months should elapse following the removal of all infected 
banana material before a new banana stand can be planted in the same field.  This is 
because the bacterium can survive in the soil for up to three months (Mwebaze et al, 
2006). 
 
De-budding or decapitation of male bud inflorescence: Prompt removal of 
inflorescence-infected plants and early de-budding of inflorescences (whether the 
disease is present or not) has been shown to also control Xanthomonas Wilt of 
bananas (Blomme et al, 2009). 
 
This reduces the risk of floral infection by insect vector transmission. Studies have 
shown that suckers do not become infected when pseudo-stems with infected 
inflorescence were removed at an early stage (Blomme et al, 2009). 
 
Cultivars whose male bracts and flowers persist longer also reduce their chances of 
floral infection. De-budding or bagging immediately after the last hand is formed on the 
bunch has been shown to be quite effective in the control of floral infections (Blomme et 
al, 2009). 
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Sterilizing garden tools and equipment: Farmers sterilize tools especially knives 
used in harvesting bunches to avoid spread of the bacteria from one plant to another. 
Tools are disinfected using either fire or dipping the tools in sodium hypochlorite 
solution. However the cost of sodium hypochlorite solution in rural areas makes this 
way of control difficult. 
 
2.7.4b Chemical and biological control 
There is currently no bactericide available to destroy Xanthomonas campestris pv 
musacearum. However herbicides such as 2,4-D are available for immediate 
destruction of infected plants and hence halt the spread of the bacteria (Smith et al, 
2007). 
 
Host resistance in bananas: Most banana cultivars and genome groups are 
susceptible to the disease. Studies investigating the susceptibility of the different 
banana cultivars/genome groups to XW showed that the AAA dessert bananas are 
most highly susceptible, followed by AAA- East African Highland bananas and BB Musa 
balbisiana (wild type of banana) as the resistant cultivar (Tripathi et al, 2009b). Field 
observations show that the disease appears to be more prevalent on ‘Pisang awak’ 
(ABB), a cultivar that has more insect vectors visiting it compared to all other cultivars 
(Biruma et al, 2007). 
 
Awareness of disease among farmers:  Raising awareness about the disease  is an 
effective way to combat the spread of the Xanthomonas campestris pv musacearum 
(Tripathi et al, 2009a). However, despite the fact that there has been awareness of the 
disease among farmers, XW is still rapidly spreading and destroying banana farms in 
Uganda and neighboring countries. XW of bananas tends to cause almost similar 
symptoms to common manageable diseases such as Fusarium wilt is often confused. 
The confusion of symptoms between the two diseases makes farmers quite reluctant to 
immediately apply XW control measures (Mwangi et al, 2007). There is need for proper 
eradication and containment measures for XW driven by accurate detection of XW in 
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infected plants/plant materials; consequently, an on-site/field based diagnostic tool for 
XW is very much required. 
 
2.7.5 Banana resistance to Xanthomonas Wilt of bananas through genetic 
engineering 
Tripathi et al (2010) transformed bananas with the hypersensitive response assisting 
protein (Hrap) gene to enhance the resistance to XW of bananas, by inducing the 
hypersensitive reaction. The Hrap gene was originally isolated from sweet pepper 
(Capsicum annum) and transformed into tobacco plants. The transgenic tobacco plants 
were able to induce a hypersensitive reaction (HR) to bacteria pathogens. In Tripathi’s 
invitro experiment, four of the transgenic lines (a transgenic line consists of 2-6 banana 
plants) inoculated with Xcm cultures remained healthy and four of them showed 
symptoms 28 days after inoculation instead of the normal 14 days after inoculation 
(Tripathi et al, 2010). The transgenic lines that showed delayed or no symptoms were 
then potted and put in the glass house. Six of the 8 transgenic plants showed no 
symptoms until 60 days past inoculation. One showed leaf symptoms but did not spread 
to other part of the plants. This indicated that banana plants can resist Xanthomonas 
wilt with the help of the Hrap gene. 
 
Namukwaya et al (2012) also transformed bananas with the Pflp gene that conferred 
resistance to XW of bananas. The Pflp gene was also isolated from sweet pepper. The 
gene is part of the protein Ferredoxin-I that is involved in metabolic pathways such as 
photosynthesis and lipid reduction. The gene has been able to enhance resistance in 
tobacco against pathogens such as Erwinia and Pseudomonas (Namukwaya et al, 
2012 ).Of the nine transgenic lines that were successfully transferred to potted plants 
from in vitro, eight of them were resistant to Xanthomonas wilt for the duration of the 
experiment;60 days after inoculation. The control plants became diseased and wilted 
away. This revealed that the Pflp gene enhanced banana resistance to Xanthomonas 
wilt. 
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2.8 An overview of plant pathogen diagnostics focusing on Xanthomonas wilt of 
bananas 
2.8.1 DNA based methods for detection of plant pathogens 
2.8.1a Conventional PCR 
Polymerase chain reaction (PCR) applications are the most common DNA-based 
methods used to detect plant pathogenic bacteria. PCR involves making millions of 
copies of a target DNA sequence, using the enzyme Taq polymerase. Two primers 
(forward and reverse) which are single short DNA strands complementary to the target 
DNA sequence provide the desired specificity. The two primers are usually 25-30 base 
pairs. The process involves three steps; denaturation, the separation of the double 
strands of DNA at high temperatures usually about 94-98◦C, annealing where the 
primers hybridize through complementary base pairing to the single stranded DNA at 
lower temperatures approximately 55-65◦C and lastly elongation, the addition of 
nucleotides to the single strands by the Taq enzyme creating a copy of the DNA section 
at a temperature of 72◦C. The cycle is usually repeated 34- 40 times. The  PCR assay 
typically consisting of the 2 primers, the enzyme Taq polymerase, magnesium chloride, 
deoxynucleoside triphosphates(dNTPs) and water are usually performed in volumes of 
10-50µl. The PCR reactions are usually run by thermal cyclers and the PCR product 
visualised by gel electrophoresis or staining. 
 
Diagnosis of plant pathogens using PCR depends  on two keys; the target sequence 
chosen to design primers and the extraction method of DNA (Weller et al, 2006). The 
target sequence has to be specific to the DNA of the pathogen and the extraction 
method must provide clean pure DNA to avoid inhibiting the role of Taq polymerase 
during PCR. The main advantage of conventional PCR is its highly sensitive and can 
detect even small amounts of DNA. Plant pathologists aim to improve its specificity and 
sensitivity and this has been done through the use of nested PCR. Nested PCR 
involves running two consecutive PCR reactions, where by a second set of primers 
detects a sequence within the initial PCR amplicon produced by the first set of primers 
(Ward et al, 2004).  
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2.8.1b TaqMan real time PCR 
This differs from conventional PCR by using a probe and providing a ‘real time’ analysis 
of the reaction. This is achieved by the binding of a probe (single stranded DNA labeled 
with a fluorescent reporter dye at one end and quencher dye at the other end) to the 
target DNA sequence between the primers. When in close proximity, the quencher 
prevents the reporter from fluorescesing. The probe will bind to the complementary part 
of the target sequence and is degraded when Taq polymerase begins extension. This in 
turn releases the reporter dye to give off fluorescence. The amount of fluorescence 
released is equal to the amount of DNA generated (PCR amplicon) (Ward et al, 2004). 
The fluorescence is measured throughout the cycle hence providing ‘real time’ analysis 
of the reaction kinetics and allowing quantification of specific DNA targets (Weller et al, 
2006). Real time PCR is also quicker as there is no need to run the PCR amplicons on 
agarose gels as with conventional PCR. 
 
2.8.2 Conventional PCR assays for detection of Xcm 
Lewis-Ivey et al (2010) carried out PCR for detecting Xcm targeting the conserved 
sequences of the hypersensitive response (Hrp) operon of the hypersensitive response 
(Hrp) gene cluster. The Hrp genes that are found in many plant pathogenic bacteria 
determine pathogenicity in hosts and hypersensitivity in resistant or non-hosts. HrpB 
sequences are highly conserved in Xanthomonas strains.  
 
Studies by Leite et al (1994) indicated that phytopathogenic Xcm strains could be 
detected and identified by analysis of DNA fragments amplified by use of hrp gene 
specific primers. Cuppels et al (2006), later developed primers (RST65/RST69) based 
on the hrpB sequences to detect Xanthomonas campestris pv vesicatoria that causes 
bacterial spot in tomatoes. However the primers also hybridized DNA templates from 
other Xanthomonas campestris pathovars including Xcm. Based on Cuppels’ study, 
Lewis-Ivey et al (2010), designed primers (XW1F and XW3R) specific for Xcm that 
showed the great variability between Xcm and other X. campestris pathovars. The 
primers successfully targeted Xcm but hybridized non-target DNA templates from X. 
axonopodis pv vasculorum (Xav) and Xvh strains. Due to the close genetic similarity 
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within the Xanthomonas genus it is challenging to design species-specific primers 
without the use of the highly conserved sequences such as B-gyrase and hrp gene 
clusters. However the chances of non-target reactivities with other pathovars are also 
high. 
 
Adikini et al (2011), also designed primers targeting the intergenic regions of the Xcm 
based on the Xcm draft genome sequenced by the University of Oklahoma Genome 
center. The study used the variability of the intergenic regions of Xanthomonas as their 
basis to design primers specific for Xcm. A total of 48 primer pairs were developed and 
tested for their specificity to Xcm.  According to Adikini et al (2011), the primers Xcm12, 
Xcm35, Xcm36, Xcm38, Xcm44, Xcm47, and Xcm48 were specific for Xcm.  
 
Adriko et al (2011, also carried out a multiplex polymerase chain reaction; The first set 
of primers (GspDmFR) target a 265-bp region of the gene encoding the general 
secretion pathway protein D (GspD) in Xcm while the second set of primers (NZ085F/R) 
target a hypothetical protein in Xcm. The primers were designed from Xcm sequences 
found in GenBank and using the NCBI blast tool. Internal controls used were primers 
targeting the 16S rDNA conserved among bacteria and the 26S mitochondrial rDNA 
conserved in plants. According to the Adriko’s study, primers targeting GspD 
(GspDmF/R) only amplified DNA templates from Xcm strains while the primers targeting 
the hypothetical protein (NZO85) amplified not only Xcm but also DNA templates from 
Xav and Xvh strains. 
 
2.8.3 Antibody based assays for detection of Xcm 
A polyclonal antibody assay has already been developed for Ugandan Xcm strains by 
IITA (Nakato et al, 2011). The polyclonal antibody assay was able to detect Xcm from 
infected banana plant parts such as the corm and pseudo-stem. Further plans are now 
underway to develop lateral flow devices for use in the field at the border controls. 
 
The DSMZ Plant Virus team in Germany also developed an antiserum for the detection 
of Xcm (DSMZ, 2012) available in a lateral flow device.  
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2.9 On-site/Field diagnostic tools currently used in plant pathogen detection 
On-site detection tools have many advantages, not only are they less costly and require 
no major laboratory tools but they can be used in rural areas and by non-experts in the 
field of science. 
 
2.9.1 Enzyme-Linked Immunosorbent Assay and Lateral Flow Devices 
ELISA has been the first and most common method plant pathologists have used to 
diagnose plant disease. This assay makes use of antibody-antigen reactions. The 
primary antibody binds to the antigen, and the secondary antibody usually attached with 
an enzyme binds to the primary antibody. In the presence of a substrate, the enzyme 
reacts to produce a colour change which  indicates a positive result. Monoclonal and 
polyclonal antibodies have been developed for detection of many phytopathogenic 
bacteria in ELISA formats. ELISA assays are quite sensitive to bacterial pathogens from 
symptomatic plants and fresh cultures. 
 
Despite their sensitivity of ELISA assays they have to be performed in a lab so there is 
a need for onsite detection and identification of plant pathogens without the use of 
traditional multi-well ELISA plates. The development of immunochromatographic 
assays/format such as the lateral flow device has made this possible. This flow test 
involves two sources of antibody (polyclonal or monoclonal) one of which is immobilized 
onto a nitrocellulose-based membrane using a sophisticated reagent dispenser while 
the other is sensitized onto blue-dye latex particles (El-badry, 2005). 
 
The sensitized latex is then airbrushed onto a conjugated release pad and sealed 
together with the membrane and an absorbent pad into a plastic housing. Specific 
antigen is ‘sandwiched’ between the immobilized antibody and the antibody-sensitized 
particles and immune complexes (Danks and Barker, 2000; see Figure 2). This usually 
gives off a colour change seen as line on the membrane indicating positive results. 
Results can be achieved in less than 10-15 minutes, and often within 2-3 minutes. 
Lateral flow devices are not so costly as ELISA and are easy to learn, use and do not 
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need laboratory equipment which makes them good for field use. One step LFDs have 
been developed for plant pathogens such as Potato Y potyvirus- PVY, Potato A 
potyvirus, (Danks and Barker, 2000), Tomato mosaic virus, Pepino mosaic virus. 
 
 
Figure 2: Image of the Lateral flow device (Danks and Barker, 2000) 
[Note:  The analyteis placed onto the release pad,and the target specific antibody 
coated with the coloured latex beads will bind to the analyte, and move to the test zone 
and the complex will bind to the immobilised species specific antibody. The test result 
will be visualised with two lines; a test line and control line.] 
 
2.9.2 Loop-mediated isothermal amplification (LAMP) assays 
Recent studies in plant pathogen detection now involve  the use of the LAMP (loop 
mediated isothermal amplification) a novel technique that amplifies nucleic acid 
sequences with high specificity, sensitivity and rapidity under isothermal conditions. 
Unlike PCR, LAMP is characterized by the use of 6 or 4 primers recognizing, 
respectively 8 or 6 distinct regions of the target DNA and the reactions proceed at a 
single temperature of around 65°C using Bst polymerase. An inner primer containing 
sequences of the sense and antisense strands of the target DNA initiates the LAMP. 
The following strand displacement DNA synthesis primed by outer primer releases a 
single-stranded DNA. This then serves as a template for DNA synthesis primed by the 
second inner and outer primers that hybridize to the other end of the target, which 
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produces a stem loop DNA structure (Notomi et al, 2000). LAMP is based on the 
principle of auto cycling strand displacement DNA synthesis performed by the Bst 
polymerase, for the detection of a specific DNA sequence (Rigano et al, 2010). The 
cycling reaction produces an accumulation of about 109 copies of the target DNA in less 
than an hour (Notomi et al, 2000). Amplification efficiency in LAMP is extremely high 
(Kiatpathomchai et al, 2008). LAMP does not require a thermo cycler making it an even 
less costly technique, with a range of detection options available. For example LAMP 
assays can also be formatted in to LFDs, which have been successfully used for the 
detection of some plant pathogens such as Citrus canker (Rigano et al, 2010). 
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2.10 Study Outline 
2.10.1 Aim 
The aims of the study were: 
• to develop field-based diagnostic tools for Xanthomonas campestris pv 
musacearum (Xcm) detection and 
• to improve knowledge of the host-range of Xcm and X vasicola (Xv) pathovars 
and genetic diversity of Xcm isolates in order to enhance better target control 
practices. 
 
2.10.2 Rationale 
XW of Banana is a relatively new and emerging disease that is a great threat to banana 
production in Uganda. The current control methods for this disease are largely based 
on planting clean material and on the early and accurate detection of infected plants. At 
the time of commissioning this study the diagnostics for Xcm were limited to 
conventional PCR  requiring  laboratory access.  Most banana growing regions are far 
from the nearest laboratories that are able to diagnose this disease.  It was considered 
therefore that a major advance in progressing timely and effective control options with 
farmers and multipliers/distributors of planting material would be the development of a 
diagnostic that was suitable for use in the field and/or in basic facilities.  
 
2.10.3 Objectives 
1. Pathogenicity studies/tests performed with strains of Xcm and Xv pathovars on 
banana (Musa spp), maize, sugarcane and sorghum to support a pathovar 
designation for Xcm with Xv. 
2. Prepare polyclonal antibodies to Xcm, validate efficacy using a standard ELISA  
format as a Lateral Flow Device. 
3. Evaluate existing diagnostic tools for detection of Xcm. 
4. Assess genetic diversity among populations of Xcm from Western Uganda based 
on SNP markers  
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3. MATERIALS AND METHODS 
3.1 Bacterial collection and testing templates 
3.1.1 Bacterial strains 
All bacterial strains used in this study are presented in Table 1 and were cultured from 
the National Collection of Plant Pathogenic Bacteria (NCPPB, The Food and 
Environment Agency (Fera, York, UK)).  The bacterial species and pathovars were 
selected to provide a good representation of Xanthomonas and non-Xanthomonas 
strains for purposes of testing the specificity of the diagnostic tools under evaluation. 
 
3.1.2 DNA extraction 
Bacterial strains (Table 1) were streaked and incubated on YDC (Bacto Agar 15g/l, 
yeast extract 10g/l, CaCO3 20g/l, D-Glucose 20g/l(Dextrose) and de-ionized water 1l) 
media at 25°C for 48 hours. Genomic DNA was extracted from a 10µl loop of bacterial 
growth taken from an area of contiguous colonies using the QiAamp DNA Mini Kit 
following the manufactures protocol. About 200µl at a concentration of approximately 
34ng/µl of DNA was yielded and kept at -20°C in labeled 1.5ml eppendorfs. 
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3.2 Evaluating the existing PCR diagnostic tools for Xanthomonas campestris pv 
musacearum 
Currently available conventional PCR based assays for detection of Xcm were 
assessed against different bacterial strains (Table 1) for their specificity.  The primer 
and amplification conditions are provided in Table 2. 
 
Conventional PCR reactions were composed as follows: each 25µl PCR reaction 
contained 1µl of DNA template, 12.5µl of 2 x PCR Master Mix (Thermo Reddy Mix), 1µl 
of each forward and reverse primer from a  stock of 10µM and 9.5µl of nuclease–free 
water. Water was used as a non-template control (in the place of DNA) for each 
experiment. The PCR reactions were performed in aGeneAmp PCR system 9700, 
Applied Biosystems. The PCR Assays were done in duplicates to minimize any errors 
and get accurate results. 
 
PCR amplicons of 5µl were then separated by agarose gel electrophoresis in 1% 
agarose gels in 1x TBE (Tris/borate/EDTA) at 130V for 60 minutes. Quick load 2 log 
DNA ladder was used to evaluate the sizes of the PCR amplicons under ethidium 
bromide staining. 
 
Table 2: Conventional PCR primers for Xanthomonas campestris pv musacearum 
and cycling conditions 
Conventional PCR Primers Cycling conditions Expected amplicon 
size 
XW-1F 
5’GTCGTTGGCACCATGCTCA 3’ 
 XW-3R 
5’TCCGACCGATACGGCT 3’ 
(Lewis Ivey et al, 2010) 
Denaturation at 95ºC for 
5min,then cycle at 95ºC 
for 30s,annealing at 55ºC 
for 30s, elongation at 
72ºC for 30s for 30 
cycles then 72ºC for 
5minutes  
214bp 
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GspDm-F 
5’GCGGTTACAACACCGTTC 3’ 
 GspDm-R 
5’AGGTGGAGTTGATCGGA 3’ 
(Adriko et al, 2011) 
Denaturation at 95ºC for 
3min, then cycle at 95ºC 
for 20s,annealing at 64ºC 
for 15s, elongation at 
72ºC for 60s for 32 
cycles then 72ºC for 
3minutes  
265bp 
NZ085F 
5’CGTGCCATGTATGCGCTGAT 
3’ 
NZ085R 
5’GAGCGGCATAGTGCGACAGA 
3’ 
(Adriko et al, 2011) 
Denaturation at 95ºC for 
3min,then cycle at95ºC 
for 20s,annealing at 64ºC 
for 15s, elongation at 
72ºC for 60s for 32 
cycles, extension at72ºC 
for 3minutes 
349bp 
Xcm12F/Xcm12R 
Xcm35F/Xcm35R 
Xcm36F/Xcm36R 
Xcm38F/Xcm38R 
Xcm44F/Xcm44R 
Xcm47F/Xcm47R 
Xcm48F/Xcm48R 
(Adikini et al, 2011) 
Denaturation at 94ºC for 
5min,then cycle at 94ºC 
for 20s,annealing at 60ºC 
for 20s, elongation at 
72ºC for 60s, for 40 
cycles, extension at 72ºC 
for 10minutes  
360bp 
480bp 
420bp 
650bp 
350bp 
370bp 
450bp 
 
3.3 Preparation of ELISA polyclonal antibodies specific for Xcm 
Polyclonal antibodies for Xcm (for NARO-Uganda) were prepared at Fera. Only one 
rabbit was immunized with a pooled sample of 6 isolates of Xcm (see Table 3). To 
induce different antigenic profiles in the bacterium and potentially antibody production 
reactions in the inoculated rabbit, the isolates were first grown on a nutrient rich medium 
(YDC; 24hrs at 24ºC) followed by nutrient poor medium (Nutrient broth; 24 hrs at 24ºC 
with gentle shaking).  Bacterial growth was harvested by centrifugation and re-
suspended in 1 x PBS (Phosphate Buffered Saline). This was then mixed with Freunds 
complete adjuvant  and used to immunise the rabbit first.  For the following 3 
immunisations  Freunds incomplete adjuvant was used.  This was done over the course 
of four months. Three types of bleeds were harvested: 
 
 A pre-immunisation - bleed for use as the negative rabbit sera control (the rabbit 
was bled prior to injection with the Xcm cells (the immunogen)) 
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 A post immunisation-bleed for use as the test Xcm antibody (the rabbit was 
injected with the Xcm cells to raise the antibody, and then bled)  
 A bleed from a rabbit immunized with CVYV as a non-related antibody (raised 
against CVYV in a different piece of work). 
 
These sera were harvested, purified by HiTrap Protein G column (GE Healthcare) 
following the manufacturer's protocol and assessed for protein concentrations. 
 
Table 3:Xcm strains used to raise antiserum in rabbit 
NCPPB 
number 
Species Country of 
Origin 
Year 
isolated 
4378 Xanthomonas campestris pv 
musacearum 
Uganda 2007 
4387 Xanthomonas campestris pv 
musacearum 
D. R. Congo 2007 
4389 Xanthomonas campestris pv 
musacearum 
Rwanda 2007 
4392 Xanthomonas campestris pv 
musacearum 
Tanzania 2007 
4433 Xanthomonas campestris pv 
musacearum 
Burundi 2008 
4434 Xanthomonas campestris pv 
musacearum 
Kenya 2008 
 
3.3.1 Preliminary testing of the non-purified polyclonal antibody 
A panel of bacteria was grown to evaluate the specificity of non-purified Xcm antibody 
(see Table 1).  The ELISA was performed at room temperature except for the 
incubations at  33°C for 1 hour.  Antigen coated  plates were always first washed and 
dried before use. A 10µl loop of bacteria growth from new cultures of the bacterium 
under test was first re-suspended in 5mls of PBS buffer. The re-suspension was 
adjusted to a concentration of 109 cfu/ml using a spectrophotometer at 650nM 
(wavelength). To make a 1 in 100 dilution of the coating buffer(15mM Na2CO3, 35mM 
NaHCO3, ph 3.6) and bacteria, 150µl of the bacterial cell re-suspension was added to 
14.85ml of coating buffer to make a concentration of 107 cfu/ml (coating buffer + 
bacteria). The plates were washed with PBST(phosphate buffered saline + tween) three 
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times in between incubations. Detection was performed using a plate trapped antigen 
ELISA assay (Indirect ELISA assay), whereby the antigen (test bacteria) is bound to the 
plastic plate and then incubated with the Xcm polyclonal antiserum for 2 hours at 33◦C. 
Binding of the Xcm polyclonal antiserum to the test bacteria is detected using a-goat 
anti-rabbit polyclonal (secondary antibody) labelled with the enzyme Alkaline 
Phosphatase (AP). The secondary antibody was diluted in PBST + 0.2% BSA (bovine 
serum albumin) at concentration of 1:4000. PNPP (p-Nitrophenyl Phosphate)  was used 
as the substrate (see Figure 3).  The plates were then incubated for 1 hour in the dark 
at room temperature. The plates were read at 405nm after 1 hour. 
 
Figure 3: Schematic of indirect ELISA. 
[Note: Ag is the test bacterium; primary 
antibody is the polyclonal antibody raised 
against Xcm and the secondary antibody is 
the anti-goat/anti-rabbit antibody (Image is 
from Thermos scientific website]]. 
 
Each plate was divided into three groups of four columns (see Figure 4). Each well was 
coated with 100µl of the bacteria (107 cfu/ml; see Table 1). The columns 1 to 4 were 
titrated with antiserum raised against Xcm (positive sera), columns 5 to 8 were titrated 
with pre-rabbit bleed and columns 9 to 12 were titrated with post-rabbit bleed against 
CVYV. The three rabbit bleeds were titrated from the rows A to H with 1:2K as the initial 
dilution to 1:256K (2-fold dilutions). Standard protocols were used in carrying out this 
ELISA experiment (see Appendix 1). 
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 Post-Xcm bleed Pre-Xcm bleed CVYV bleed 
 1 2 3 4 5 6 7 8 9 10 11 12 
A 1:2K             
B 1:4K             
C 1:8K             
D 1:16K             
E 1:32K             
F 1:64K             
G 1:128K             
H 1:256K             
Figure 4:Microtitre ELISA plate layout showing the arrangement, wells and 
dilutions of the three rabbit bleeds in the preliminary testing of the non-purified 
polyclonal antibody. 
 
3.3.2 Validation of the purified polyclonal antibody assay 
The Xcm antibody was purified and assessed for sensitivity and specificity compared to 
the non-purified polyclonal antibody. A comparison was also made to an Xcm polyclonal 
developed by the International Institute of Tropical Agriculture (IITA) (kindly provided by 
Dr. Lava Kumar, IITA Ibadan, Nigeria). 
 
3.3.2a Sensitivity testing 
Initial testing on sensitivity was performed on a known positive (Xanthomonas 
campestris pv musacearum NCPPB 4434) and two known negative strains 
(Xanthomonas arboricola pv celebensis (Xac) (NCPPB 1630) and American Foulbrood 
Bacteria (AFB). For each strain three ELISA plates were coated with a bacterial 
suspension of 107 cfu/ml and treated as below and as presented in Figure 5A-C:  
 
 Plate 1 was titrated at dilutions of 1:1K to 1:256K (column 2-10) with rabbit pre-
bleed (row B to D) and CVYV antiserum (row E to G). 
 Plate 2 was a duplicate of Plate 1, but titrated at dilutions of 1:1K to 1:256K 
(column 2-10) with the IITA Xcm polyclonal antibody (row B to D) and the effluent 
from the purified Xcm-polyclonal of Fera (E-G). 
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 Plate 3 had the same row/column arrangement, but titrated at dilutions of 1:1K to 
1:256K (column 2-11) with the non-purified polyclonal antibody (B to D) and at 
dilutions of 1:4K to 1:1,000K (column 2-10) the purified antibody (E to G). 
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Figure 5C: Plate 3 
Figure 5: Microtitre plate arrangement for sensitivity evaluation of the purified 
ELISA polyclonal antibody on 
against IITA’s polyclonal antibody
assay. 
 
3.3.2b Specificity testing 
Based on the results of the sensitivity screen, specificity was further tested against the 
strains in Table 1 with the 
antibody and the CVYV antiserum.  For each bacterium at a constant concentration of 
107 cfu/ml tested in 2-fold-dilutions of antibody from 1:2K to 1:128K for IITA
purified Xcm and CVYV antisera and of 1:32K to 1:2,000
6). Each strain and antiserum treatment was replicated once per plate and each plate 
was duplicated. To determine the threshold between positive and negative results, we 
used the 3  (that is 3 times the mean OD values at different dilutions respectively) of 
the OD values of the known negative plates which were also negative 
sap and EFB). This method is commonly used to determine the
threshold (Bioreba – Agro diagnostics, 
et al,1998). Other methods for determining the threshold value
considered but the OD values were still too low (
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provides for lower percentage of 
3SD(standard deviation) (Sutula 
 
 IITA Xcm poly 
    
A 1:2K    
B 1:4K    
C 1:8K    
D 1:16K    
E 1:32K    
F 1:64K    
G 1:128K    
H 0    
*Purified Xcm antibody used at a dilution series of 1:32K to 1:2000K.
Figure 6: Microtitre plate layout showing the arrangement on each ELISA 
microtitre plate and dilutions of the different polyclonal antibody against the 
antigen. 
 
3.3.3 Assessment of the ELISA polyclonal Lateral Flow Device
The purified antibody was then passed on t
UK) for development as a Lateral Flow Device (LFD). 
the LFD was then assessed by Fera.
 
3.3.3a Specificity of the LFD
The specificity of the LFDs was tested with the strains 
dilution of 1:10 solution (20
180µl of LFD extraction buffer that comes with the kit) was added to each LFD, and the 
results (presence of a blue line) read after
 
3.3.3b Sensitivity testing of the LFD
Sensitivity of the LFD was tested with a known positive 
described below. 
false positives compared to the 2
et al,1986). 
Non-purified 
Xcm 
Purified Xcm* 
      
      
      
      
      
      
      
      
      
 
o Forsite Diagnostics (Sand Hutton, York, 
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µl of bacterial suspension at concentration of 10
 10 minutes. 
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µl from a 
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Without banana sap: Sensitivity of the LFD was tested with bacteria suspended in LFD 
extraction buffer solution (Foresite Diagnostics) at concentrations of 108, 107, 106, 105, 
104 and 103 cfu/ml for NCPPB 4434. 100µl from each concentration was added to the 
LFD. Results were read after 10 minutes. 
 
With banana sap: Fresh healthy banana leaf stalk were cut 2.5cm by 5cm and placed 
for 10 minutes in the LFD extraction buffer to allow the sap to ooze out. After the 10 
minutes, 180µl of the banana exudate mixture (sap and buffer) was added to 20µl of a 
cell suspension of NCPPB 4434 at a concentration of 108 cfu/ml, which was then diluted 
from 107 to 103 cfu/ml with banana exudate mixture. 100µl of each cell suspension was 
then added to the LFD. Results were read after 10 minutes. 
 
With crushed leaf: Fresh healthy banana leaf of about 0.25g was cut up and placed in 
LFD extraction buffer bottle containing small ball bearings (as supplied by Foresite 
Diagnostics), and shaken for 30 seconds to crushed the leaf material. 180µl of the 
banana exudate mixture (leaf and buffer) was added to 20ul of a cell suspension of 
NCPPB 4434 at a concentration of 108 Cfu/ml, which was then diluted from 107 to 103 
cfu/ml with exudate mixture. 100µl of each cell suspension was then added to the LFD. 
Results were read after 10 minutes. 
 
3.4 Pathogenicity trials 
To support the proposal of a new pathovar of Xcm to Xanthomonas vasicola pv 
musacearum, pathogenicity characterisations/comparisons of the Xanthomonas 
vasicola pathovars are needed (George, 2005) on maize, sorghum, sugarcane and 
banana.  
 
3.4.1 Bacteria and preparation of inoculum 
The bacteria species and pathovars included this study included strains from Xcm and 
Xvh, Xvv, Xanthomonas axonopodis pv vasculorum (causes Gumming disease in 
sugarcane), and other common plant pathovars; the X. campestris pathovars 
campestris, vesicatoria and pelagonii that are not known to cause disease in banana, 
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maize, sugarcane and sorghum, respectively. Other non-Xanthomonas strains included  
Paenibacillus larvae. The strain list is provided in Table 1. 
 
Bacteria were grown on YDA media at 25ºC for 48 hours. Using a 10µl loop, pure 
colonies were removed from the plate and re-suspended in sterile water. The bacterial 
suspensions were then adjusted to the required OD using a spectrophotometer 
(wavelength at 650nm) with either sterile water or addition of bacteria into the 
suspension. 
 
3.4.2 Plants to be inoculated and growing conditions 
Banana (varieties Cavendish and Tropicana (AAA)), sugarcane (variety unknown), 
maize (variety cisko) and sorghum (variety unknown) young plants (almost seedlings) 
were grown under glasshouse conditions at Fera. A minimum temperature of 25ºC was 
maintained. See Appendix 2 for full pathogenicity plan used in the study. 
 
3.4.3 Pilot trials 
Pilot trials of banana, maize and sorghum were carried out to determine the level of 
inoculum that would enable pathogenicity to be achieved and for familiarization on what 
symptoms to expect and the best inoculation method. About 8 young maize and banana 
plants were inoculated at the base of the stems using a 1ml syringe with 100-200µl of 
bacterial suspensions of Xcm (NCPPB 4434, NCPPB 4378), Xvv (NCPPB 702,NCPPB 
795), Xvh (NCPPB 1060) and Xanthomonas axonopodis pv vasculorum (NCPPB 796, 
NCPPB 899) at cell concentrations of 107 cfu/ml.  
 
The controls were either left untreated or inoculated with sterile water. A pilot on 
sugarcane and sorghum was not attempted due to a shortage of sugarcane plants. 
Sedum plants (Umesha et al, 2007) were used as a positive plant indicator in the pilot 
trial. Symptom expression was recorded for 5 weekdays. Photographic evidence of 
symptoms was taken. 
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3.4.4 Main pathogenicity trials 
Based on the results of pilot trials, a full pathogenicity trial was conducted on maize, 
sorghum, sugarcane and banana against the bacterial strains, see Appendix 2. 
 
3.4.4a Setting-up of main pathogenicity trials 
Four plants of maize, banana and sorghum were used for each of the 3 treatments: 
untreated, water controls and test bacteria (in total 12 plants). For the sugarcane, due to 
the number of plants available, three plants were used for each treatment.  
 
Inoculation of water control and test bacteria treatments was as described for the pilot 
trial. The plants were injected at the base of the stem with about 100-200µl of inoculum 
standardized across strains under test at 107 cfu/ml. The plants were then labeled with 
numbers 1 to 112 and randomized. 
 
3.4.4b Viability of the bacteria 
The viability and cell concentration of the bacterial suspensions used in the inoculation 
were determined by lawn plating 100µl on to YDC media and incubating at 25ºC for 48 - 
72 hours. 
 
3.4.4c Re-isolation of the pathogen and proof of Koch’s postulate 
Re-isolation of the bacteria was attempted at around 5 weeks post-inoculation 
irrespective of whether the plants exhibited symptoms or not. One or two leaves and 
leaf stalks of each treatment were picked and, depending on symptom presence, either 
part of the leaf bordering a diseased and healthy area or proximate to the inoculation 
wound taken and cut up in to small pieces (0.1 to 0.3g). The leaf pieces were then 
crushed and soaked in 1ml of PBS and left to stand for at least 5 to 30 minutes to allow 
bacteria to ooze out. Single isolate cultures were then obtained by streaking out a few 
10µl loops of the crushed leaf-PBS solution on YDC media, incubated at 25ºC for 48 - 
72 hours. 
 
63 
For colonies that conformed to Xanthomonas morphology, confirmation of re-isolation of 
the inoculated strain was achieved by PCR using the primers of Adriko et at (2011) for 
Xcm and Xvv and Xvh. Re-isolates from plants that had been inoculated by other 
Xanthomonas and non-Xanthomonas strains were identified visually; colonies that 
looked like Xanthomonas were assumed to be those that had been inoculated into that 
particular plant. 
 
3.5 Characterizing Western Uganda isolates using the SNP primers (Wasukira et 
al, 2012) 
3.5.1 Sample collection 
Xcm samples from Western Uganda were collected with the help of IITA staff in 
Uganda. The bacteria were isolated from leaves, pseudo-stems and corms. Samples 
were from the district of Kabale, Ntugamo and Bushenyi. 45 Isolates from leaf samples 
were streaked and re-grown on YDC media, incubated at 28ºC for 48 hours. 
 
3.5.2 DNA extraction 
Samples (Table 4) were grown in Kings Broth (10ml) overnight, and 1ml of the liquid 
bacteria culture centrifuged at 4000rpm at 4ºC for 10 minutes to obtain a pellet. The 
supernatant was poured off and the tube inverted to dry it, the pellet was re-suspended 
in 2ml of TE buffer (25mM Tri-HCL ph8.0, 10mM EDTA), 300µl of the re-suspension 
was placed in 1.5ml eppendorfs and the rest frozen. The cells were then lysed with 12 
µL of 20mg/ml lysozyme and 1.5µl RNase at 10mg/ml and incubated at room 
temperature for 10 minutes. Further lysis was done with 17µl of 10% sodium dodecyl 
sulphate (SDS) and incubated on ice for 5min. Proteins were pelleted with addition of 
170µl of 8M ammonium acetate, vortexed for 20s and centrifuged at 4ºC at maximum 
speed for 15 minutes. The supernatant carefully pipetted in to a clean 1.5ml eppendorfs 
and DNA precipitated with addition of 0.75 volume isopropanol, centrifuged for 10 
minutes. The supernatant was pipetted off and the pellet washed with 100µl of 70% 
ethanol by centrifuging at maximum speed for 5 minutes. Ethanol was pipetted off and 
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the pellet dissolved in 200µl of Tris 10mM. This was done to avoid EDTA interfering with 
PCR. 
Table 4: The new collection of Xanthomonas campestris pv musacearum isolates 
from Western Uganda isolated from leaves of infected banana plants 
Sample 
ID 
District Village Sample 
ID 
District Village 
2 Kabale Nyamishaki 43 Ntugamo Bucence 
3 Kabale Nyamishaki 45 Ntugamo Bucence 
4 Kabale Nyamishaki 46 Ntugamo Kitojo 
6 Kabale RushyebeyaI 48 Ntugamo Kitojo 
7 Kabale RushyebeyaI 49 Ntugamo Kitojo 
8 Kabale RushyebeyaI 50 Ntugamo Kitojo 
9 Kabale RushyebeyaI 53 Ntugamo Kigarama 
10 Kabale RushyebeyaI 54 Ntugamo Kigarama 
11 Kabale Kanyakutana 55 Ntugamo Kigarama 
12 Kabale Kanyakutana 59 Ntugamo Rukoni 
13 Kabale Kanyakutana 62 Bushenyi Matigi 
14 Kabale Kanyakutana 64 Bushenyi Matigi 
15 Kabale Kanyakutana 67 Bushenyi Nyabubare 
17 Kabale Nyamitooma 70 Bushenyi Nyabubare 
21 Kabale Kateramabareeba 73 Bushenyi Kizumo 
23 Kabale Kateramabareeba 76 Bushenyi Nyakabingo 
30 Kabale Kabugarama 77 Bushenyi Nyakabingo 
34 Ntugamo Ihuriro 81 Bushenyi Keijengye 
36 Ntugamo Ihuriro 83 Bushenyi Keijengye 
39 Ntugamo Nyakagongo 84 Bushenyi Keijengye 
40 Ntugamo Nyakagongo 87 Bushenyi Kibaare B 
42 Ntugamo Bucence 90 Bushenyi Kibaare B 
[Note: Genomic DNA was extracted from the samples and PCRs run. Only samples that 
had at least 20ng DNA/µl  were used as templates for PCR. PCR digests were done 
according to the conditions of the enzyme (see Table 6)] 
 
3.5.3 Primers and PCR conditions 
PCR gradients had to be done for the primers to determine the best annealing 
temperature that will give the best product size. PCR reactions were 20µl; 2µl PCR 
buffer, 0.6µl MgSO4  , 1.6µl dNTPS, 1µl forward primer,1µl reverse primer,12µl 
nuclease free  water, 0.8µl of Taq and 1-2µl of DNA template. PCR amplicons were 
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separated out in 2% agarose gel in 1 x TAE buffer for 45 minutes at 80V. Band sizes 
were evaluated by the Gene ruler 1kb DNA ladder. 
 
The PCR digest reactions were 25µl; 2.5µl PCR digest Buffer, 0.2-0.5µl depending on 
the enzyme, 17µl of water and 5µl of PCR amplicon. The reactions were incubated at 
37ºC for 2 hours. The products were run in 2% agarose gel in 1 x TAE buffer for 50 
minutes at 80V. Band sizes were evaluated with the Gene ruler 1Kb DNA ladder. 
 
Table 5: SNP Xcm PCR primers and cycling conditions (Wasukira et al, 2012) 
Primer set PCR conditions Expected 
amplicon size 
AluACHT010000 
43FR 
Denaturation at 95ºC for 2min,then cycle at 
94ºC for 30s,annealing at 61.7ºC for 30s, 
elongation at 72ºC for 45s for 35 cycles, 
extension at 72ºC for 10 minutes 
500bp 
BgIIACHT010002 
42FR 
Denaturation at 95ºC for 2min,then cycle at 
94ºC for 30s,annealing at 61.7ºC for 30s, 
elongation at 72ºC for 45s for 35 cycles, 
extension at 72ºC for 10 minutes  
500bp 
RsaIACHT010000 
45FR 
Denaturation at 95ºC for 2min,then cycle at 
94ºC for 30s, annealing at 53ºC for 30s, 
elongation at 72ºC for 45s for 35 cycles, 
extension at72ºC for 10 minutes 
500bp 
StyIACHT010001 
40FR 
Denaturation at 95ºC for 2min,then cycle at 
94ºC for 30s,annealing at 55ºC for 30s, 
elongation at 72ºC for 45s for 35 cycles, 
extension at72ºC for 10 minutes 
500bp 
 
Table 6: SNP PCR restriction enzymes conditions (Wasukila et al, 2012) 
Primer set Enzyme Conditions Expected 
amplicon 
size 
Xcm SNP 
characterisation  
AluACHT010000 
43FR 
AluI Incubate at 
37ºC for 2 
hours 
250bp Differentiates at 
position 10,914 for 
Ethiopian strains 
NCPPB 2005 (bp C) 
and NCPPB 2251 (bp 
T).  Bp C was common 
to lineage II strains** 
BgIIACHT010002 
42FR 
BgII Incubate at 
37ºC for 2 
250bp Differentiates at 
position 12,462 for 
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Primer set Enzyme Conditions Expected 
amplicon 
size 
Xcm SNP 
characterisation  
hours Ethiopian strains 
NCPPB 2005 (bp G) 
and NCPPB 2251 (bp 
A). Bp G was common 
to lineage II strains** 
RsaIACHT010000 
45FR 
RsaI Incubate at 
37ºC for 2 
hours 
250bp Differentiates at 
position 32,848 for 
Lineage I* (bp G) and 
Lineage II (bp A) 
strains 
StyIACHT010001 
40FR 
StyI Incubate at 
37ºC for 2 
hours 
250bp differentiates at 
position 2,515 and 
2,530 for lineage I (bps 
T&C) and lineage II 
(bp C&T) strains 
[Note:  
lineage I – Ethiopia: NCPPB 2005, 2251; DR Congo: NCPPB 4387; and Rwanda 
(NCPPB 4389) 
lineage II – Uganda - NCPPB 4379, 4383, 4384, 4380, 4381, Tanzania - NCPPB 4394, 
4395, 4381, Kenya - NCPPB 4434 and Burundi - NCPPB 4433] 
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4. RESULTS 
4.1 Comparison and evaluation of existing PCR tools for detection of Xcm 
Existing PCR tools for detection of Xcm were evaluated for their specificity in order to 
form a baseline for Fera to compare ELISA and LFD formats of polyclonal detection. 
The most specific primers to Xcm strains were GspDmF/R primers from Adriko et al 
(2011), designed from a gene sequence for the secretion pathway D in Xcm. 
 
Table 7 summaries the evaluation of the PCR assays evaluated (Adriko et al, 2011; 
Lewis-Ivey et al, 2010; Adikini et al, 2011) to detect Xcm strains. All primers from the 
three studies were able to amplify DNA from Xcm strains. The primers GspDmF/R 
(Adriko et al, 2011) were shown to be specific for Xcm, without cross reaction to other 
strains. Primers NZO85 (Adriko et al, 2011) and XW 1F/3R (Lewis-Ivey et al, 2010) 
were specific to Xcm and Xvv (NCPPB 206, NCPPB 702, NCPPB 890 and NCPPB 
895), but failed to detect Xvh strains. The ‘failed’ detection of Xvh strains by these 
primers is at variance with the reported claims made for these primers. 
 
The primers Xcm12F/R, Xcm35F/R, Xcm36F/R, Xcm38F/R, Xcm44F/R, Xcm47F/R, and 
Xcm48F/R) (Adriko et al, 2011) exhibited varying levels of specificity. Although all of 
these primers were shown to amplify Xcm strains, no complete specificity to Xcm strains 
was demonstrated and cross reactivety with non-Xcm strains was evident. Primers 
35F/R were the most specific for Xcm, cross-reacting with only one, but not all, Xvv 
strains and no other strains. Primers Xcm12F/R exhibited some inconsistent cross 
reactivity to Xvv and Xvh strains; whereas primer pair Xcm 36F/R cross reacted with 
only some of the Xvv strains. Primers Xcm44F/R, Xcm47F/R and Xcm48F/R exhibited a 
range of cross reaction capabilities. These results were also not consistent with the 
results reported in Adikini’s study. 
 
In summary,the primers GspDm were shown to be the most specific primers for PCR 
detection of Xcm. Primers XW1F/3R, NZ085F/R and Xcm 36F/R are able to distinguish 
strains of Xvv and Xvh. 
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The below figures provide illustration of the r
Xcm and related strains in gel pictures
 
Figure 7: Agarose Gel pictures showing PCR results of GspDm (left) and 
NZO85 primers (right) (Adriko et al, 2011)
 
Figure 8: Agarose gels showing PCR results of XW1F/3R primers (Lewis
et al, 2010) on Xvv, Xav and 
[Note For Figures 7-8: Lanes 1, 2 and 7 
186, 899), Lanes 3 and 4 –
– X. campestris pv vesicatoria (NCPPB 423), Lane 6 
(NCPPB 4344), Lane 9 – Water
 
  
esults of the three PCR assays against 
 
, respectively, on Xvv, 
 
Xcm strains 
- X. axonopodis pv vasculorum (NCPPB 796, 
 X. vasicola pv vasculorum (NCPPB702, 795)
– X. campestris pv musacearum 
] 
 
Xcm, and Xav 
-Ivey 
, Lane 5 and 8 
69 
I.  Xcm12F/R  
III. Xcm36F/R 
V.  Xcm44F/R 
VII. Xcm48F/R 
Figure 9: Agarose gels showing PCR results of Primers 
Xcm35F/R, Xcm36F/R, Xcm
et al, 2011), respectively, on Xvv, Xav and 
 
 
II. Xcm35F/R  
 
IV. Xcm38F/R 
 
VI. Xcm47F/R 
 
 
 
 
 
[Note:  Agarose gel to the left; 
Lane 2 – X. vasicola pv vasculorum
Lane 3 – X. axonopodis pv 
vasculorum] 
 
38F/R, Xcm44F/R, Xcm47F/R, Xcm48F/R (Adikini 
Xcm 
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4.2 ELISA Polyclonal antibody assay 
Fera developed an ELISA polyclonal antibody assay (for NARO -Uganda) to detect 
Xcm. Xcm strains (NCPPB 4389, NCPPB 4433, NCPPB 4434, NCPPB 4392, and 
NCPPB 2251) were inocculated into the rabbit and the antibodies harvested within a 
period of four months. The unpurified (the serum contains antibodies and other proteins) 
polyclonal antibody was tested and evaluated against Xcm and other Xanthomonas 
strains by ELISA for specificity. It was then purified by HiTrap Protein G columnand re-
evaluated against Xcm and other Xanthomonas and non-Xanthomonas strains. The 
ELISA polyclonal assay was then sent off to Forsite Diagnostics to be formatted into a 
Lateral Flow Device (LFD). The LFD could in future be used as an on-site tool to detect 
Xcm. 
 
4.2.1 Preliminary testing of the ELISA polyclonal assay 
The polyclonal antibody assay (unpurified) was first assessed for its specificity against 
Xcm and other Xanthomonas and non-Xanthomonas strains. The negative controls 
were the pre-bleed (the serum before the rabbit was injected with Xcm strains) and a 
CVYV antibody against the CVYV.  
 
The bacterial strains (see Table 1) that were tested had been grown on YDC media for 
48 hours at 25ºC. A 10µl loop of the bacteria was then re-suspended in 5ml of PBS 
solution. The bacteria suspensions were then adjusted to a concentration of 107 Cfu/ml 
using a spectrophotometer at 650nm. ELISA was carried out according the standard 
protocol (see Appendix 1). The optical density (OD), that is the amount of colour 
produced from the wells on the ELISA plates after the addition of the substrate (PNPP) 
to the antibody conjugate (with enzyme Alkaline Phosphatase) was measured by the 
spectrophotometer specific for reading ELISA plates at 405nm wavelength.  High OD 
value meant  the polyclonal antibodies react strongly with the antigen (bacteria tested) 
and a lower OD meant less binding of the antibody to the antigen. The OD values from 
wells titrated with the negative controls was very low and consistent compared to the 
OD values from wells titrated with the Xcm polyclonal antibody, thereby confirming the 
absence of the antigen to which the control antibodies would bind. The unpurified 
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polyclonal antibody was able to detect and bind to all Xcm strains, however they cross-
reacted with Xanthomonas axonopodis pv vasculorum (Xav; causes Gumming disease 
in sugarcane) but no other Xanthomonas strains tested (see Figure 10).  
 
 
Figure 10: Summary of the ELISA polyclonal antibody assay (unpurified) 
assessed against Xcm and other Xanthomonas and non- Xanthomonas strains, 
OD values from 1:32000 dilution of the antibodies (Unpurified polyclonal, Pre-
bleed and CVYV) against the antigen. The bars represent the mean OD values of 
the 4 replicates for each strain at this dilution. The error bars represent the 
standard deviations 
[Note: Unpurified means the unpurified polyclonal antibody to detect Xcm and Pre-bleed 
is the serum before the rabbit was injected with Xcm strains, used as a control, and 
CVYV is the antibody used to detect CVYV, this was the second control. Xcm – X. 
campestris pv musacearum, Xvv – X. vasicola pv vasculorum, Xvh – X. vasciola pv 
holcicola, Xav – X. axonopodis pv vasculorum, Xcv- X. campestris pv vesicatoria, Xcc- 
X. campestris pv campestris, Xcp – X. campestris pv perlagonii, Ralstonia 
solanacearum, Pseudomarginalis pv marginalis, EFB – European Foulbrood 
 
Under a separate assessment the effect of dilution on detection was investigated.  The 
OD values from wells titrated with the unpurified polyclonal antibody (against Xcm) from 
1:2,000 to 1:256,000 (rows A to E and from columns 1 to 4 (these columns had only the 
unpurified polyclonal antibody titrated for each plate)) were decreasing with increasing 
dilution of the antibody. At 1:32,000 dilutions and higher dilutions of the unpurified 
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antibody, the OD results were still quite high as shown in Figure 11, above an OD of 1. 
This suggested that the antibody could be further diluted beginning with 1:32,000 
dilution of the antibody before we notice loss of colour change or much lower OD than 
0.5. 
 
 
Figure 11: Optical densities at 405nm of the known positive plate 7 (whole cell 
bacteria strain of Xcm NCPPB 2005) showing the sensitivity of the unpurified 
polyclonal antibody for XW at increasing dilutions. The bars represent the mean  
OD values of the 4 replicates of the strain at different dilutions. The error bars 
represent the standard deviations.The higher the OD, the higher the sensitivity of 
the antibody.  
[Note: Unpurified means the unpurified polyclonal antibody against Xcm, Neg means 
serum before the rabbit was inoculated used as a control and CVYV means the serum 
against CVYV used as a control. The colour change is still noticeable at 1:32000 dilution 
of the unpurified antibody against the antigen (bacteria tested).] 
 
4.2.2 Sensitivity and specificity of the purified polyclonal antibody 
The unpurified antibody for Xcm was purified to remove contaminant proteins and 
assessed against bacteria strains of Xcm and other Xanthomonas and non-
Xanthomonas strains, as the purification process can alter specificity. The specificity 
and sensitivity of the purified polyclonal was also compared with that of its unpurified 
Xcm polyclonal antibody of IITA (Nakato et al, 2011). We began with a dilution of 
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1:4,000 for both NARO’s purified and IITA unpurified Xcm polyclonal antibody and 
began with a 1:1,000 dilution for polyclonal antibody of IITA in evaluating the sensitivity 
of the antibodies. Based on the sensitivity results, for specificity testing, we began with a 
dilution of 1:32,000 for both unpurified and purified Xcm polyclonal antibody and 1:2,000 
for the polyclonal antibody of IITA. 
 
4.2.2a Sensitivity testing 
All three antibodies; NARO’s purified and unpurified polyclonal (developed by Fera) and 
the polyclonal antibody of IITA were able to detect Xcm. For purified and unpurified Xcm 
polyclonal antibody, colour changes were still noticeable at higher dilutions (less 
concentrations of the antibody) of 1:500k and 1:1,000k (See Figure 12) of the antibodies 
respectively. The purified polyclonal antibody showed more sensitivity than the 
unpurified polyclonal antibody at the same dilutions as expected. 
 
 
Figure 12: Graph showing the sensitivity of the three polyclonal assays against a 
known positive (whole bacteria cell of Xcm NCPPB 4434) at different dilutions of 
the antibodies. The bars represent the mean  OD values of the 4 replicates of the 
strain at different dilutions. The error bars represent standard deviations. High 
0
0.5
1
1.5
2
2.5
3
3.5
O
D
V
A
L
U
E
S
Purified
un purified
IITA
77 
OD values reveal high sensitivity of the antibody while low OD values reveal less 
sensitivity of the antibody
[Note: Purified means purified polyclonal antibody
polyclonal antibody and IITA 
dilution of the antibody or 1:2K means 1 in 2,000 dilutions of the antibody etc.]
 
4.2.2b Final specificity testing
For our specificity testing, we compared OD results from ELISA plate readings of 
purified polyclonal assay and the
determine the threshold between positive and negative results, we used the 3
3 times the mean OD values at different dilutions respectively) of the OD values of the 
known negative plates which were also negative controls (banana sap and EFB).  
Threshold values ranged from 0.26 to 0.16 for the purified polyclonal antibody and 0.24 
to 0.16 for the Xcm polyclonal
 
Table 8 summaries the results of the assessment of the purified 
antibody assay against different 
Xcm purified polyclonal and the 
each cross-reacted with Xanthomonas
NCPPB 899). In addition the 
arboricola pv celebensis (NCPPB 1630) strains at lower dilutions (high concentrations) 
of the antibody at 1:2,000 to 1:8,000 and with 3 of the 4 
species tested (NCPPB 2315, NCPPB 3205, NCPPB 3214) at 1:2,000 dilution.
 
 
 
, unpurified means unpurified 
– IITA Xcm unpurified polyclonal. 1:1K means a 1 in 1,000 
 
 Xcm polyclonal of IITA at the different dilutions. To 
 antibody of IITA (see Figure 13). 
Xanthomonas and non-Xanthomonas
Xcm polyclonal of IITA detected all 
 axonopodis pv vasculorum strains (NCPPB 796, 
Xcm polyclonal of IITA cross reacted with 
Ralstonia solanacearum
 
 (that is 
Xcm polyclonal 
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Table 8: Summary of ELISA polyclonal antibody assessment against 
Xanthomonas and non-Xanthomonas strains 
Strain NCPPB 
number 
Xcm IITA Purified 
Xcm 
Banana sap  - - 
Enterobacter spp 4168 - - 
Melissococcus plutonius EFB 6404 - - 
Pseudomonas marginalis pv marginalis 1232 - - 
Ralstonia solanacearum 2198 - - 
Ralstonia solanacearum 2315 + - 
Ralstonia solanacearum 3205 + - 
Ralstonia solanacearum 3214 + - 
Serratia marcescens 2641 - - 
Xanthomonas arboricola pv celebensis 1630 + - 
Xanthomonas axonopodis pv vasculorum 796 + + 
Xanthomonas axonopodis pv vasculorum 899 + + 
Xanthomonas axonopodis pv vasculorum 186  + + 
Xanthomonas campestris pv campestris 529 - - 
Xanthomonas campestris pv musacearum 2005 + + 
Xanthomonas campestris pv musacearum 2251 + + 
Xanthomonas campestris pv musacearum 4378 + + 
Xanthomonas campestris pv musacearum 4379 + + 
Xanthomonas campestris pv musacearum 4380 + + 
Xanthomonas campestris pv musacearum 4381 + + 
Xanthomonas campestris pv musacearum 4383 + + 
Xanthomonas campestris pv musacearum 4387 + + 
Xanthomonas campestris pv musacearum 4387 + + 
Xanthomonas campestris pv musacearum 4388 + + 
Xanthomonas campestris pv musacearum 4389 + + 
Xanthomonas campestris pv musacearum 4390 + + 
Xanthomonas campestris pv musacearum 4391 + + 
Xanthomonas campestris pv musacearum 4392 + + 
Xanthomonas campestris pv musacearum 4393 + + 
Xanthomonas campestris pv musacearum 4433 + + 
Xanthomonas campestris pv musacearum 4434 + + 
Xanthomonas campestris pv perlagonii 2985 - - 
Xanthomonas campestris pv perlogonii 529 - - 
Xanthomonas campestris pv vesicatoria 422 - - 
Xanthomonas campestris pv vesicatoria 701 - - 
Xanthomonas spp 1131 - - 
Xanthomonas spp 1132 - - 
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Strain NCPPB 
number 
Xcm IITA Purified 
Xcm 
Xanthomonas vasicola pv holcicola 1060 - - 
Xanthomonas vasicola pv holcicola 3162A - - 
Xanthomonas vasicola pv holcicola 3162B - - 
Xanthomonas vasicola pv vasculorum 206 - - 
Xanthomonas vasicola pv vasculorum 702 - - 
Xanthomonas vasicola pv vasculorum 795 - - 
Xanthomonas vasicola pv vasculorum 890 - - 
Xanthomonas vasicola pv vasculorum 895 - - 
[Note: Whole cell bacteria strains were used in the plate trap ELISA method, + means 
its positive result, and – means its negative result. The strains in red were expected to 
give off negative results but cross-reacted with the particular Xcm polyclonal antibody, 
while the strains in green gave the positive results as expected.] 
 
4.2.3 Development of the ELISA polyclonal Lateral Flow Device (LFD) 
Under this study the Xcm polyclonal antibody assay for detection of Xcm by ELISA had 
been successfully demonstrated. The polyclonal antibody assay was assessed against 
Xcm, other Xanthomonas strains and non-Xanthomonas strains for specificity. Forsite 
Diagnostics then successfully developed the purified polyclonal antibody in the format of 
a LFD (see Appendix 3). The LFD involved binding the polyclonal antibody to latex.. 
When a test sample is added to the sample pad, the bacteria co-migrate with the solute 
by absorption and ‘cross’ the detection (fixed Xcm antibody) zone. In a positive test the 
Xcm bacterium bind with the Xcm polyclonal and to the conjugate antibody-coloured 
particles to give a coloured complex (seen as a line). The conjugate coloured particles 
also migrate and bind with a second fixed control line. Two coloured lines meant it was 
a positive result and one coloured line meant it was a negative result. The LFD 
developed for NARO-Uganda ran successfully (see Figure 14). 
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4.2.3.a Specificity of the LFD
The LFD data was consistent with the ELISA; with detection of all 
and cross-reaction with Xanthomonas
3).  
 
Table 9: Results for the LFD specificity
Strain 
Xanthomonas campestris pv 
Ralstonia solanacearum 
Xanthomonas arboricola pv
Xanthomonas axonopodis pv
Xanthomonas campestris pv
Xanthomonas campestris pv
Xanthomonas campestris pv
Xanthomonas campestris pv
Xanthomonas campestris pv
Xanthomonas campestris pv
Xanthomonas campestris pv
Xanthomonas campestris pv perlogonii
Xanthomonas campestris pv
Xanthomonas spp 
Xanthomonas spp 
Xanthomonas vasicola pv holcicola
Xanthomonas vasicola pv vasculorum
[Note: 
 
Figure 14: The LFDs developed by Forsite 
Diagnostics.  
[Note: The left LFD is with Xcm
(NCPPB 4434) and the right LFD is with healthy 
leaf sap. The single line furthest from the well 
and common to both LFD 
indicates the test has worked. The 
on the left LFD indicates a positive test for the 
presence of Xcm. The single line on the right 
LFD indicates a negative test]
 
Xcm
 axonopodis pv vasculorum strains (see Appendix 
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+ a positive result (ie gave two lines; coloured test and control line) 
– a negative result (control line coloured only).  
The strains in green were expected to give positive results (the LFD was supposed to 
detect the strain), while the strains in red were expected to give a negative result, but 
instead gave positive result.] 
 
4.2.3b Sensitivity of the LFD  
The LFD was most sensitive at high Xcm cell concentrations of 108 to 106 cfu/ml (cells 
suspended in extraction buffer), with positive lines clearly visible after 10 minutes (see 
appendix 3, D-M). Weak positives were evident at 105 cfu/ml and detection was shown 
to fail at 104 cfu/ml and below. These results were then shown to be equivalent for the 
same concentrations with crushed banana leaf-extraction buffer and banana sap-
extraction buffer. 
 
Table 10: Results of the LFD sensitivity assessment against Xcm, Xav and 
Ralstonia solanacearum strains at different concentrations 
Strain Isolate 
origin 
NCPPB 
number 
Bacterial cfu/ml 
108 107 106 105 104 
Ralstonia solanacearum  3205  --  -- --  --  --  
Xanthomonas axonopodis pv 
vasculorum 
 796  ++  ++  ++ +  -- 
Xanthomonas campestris pv 
musacearum 
Ethiopia 2251  ++  ++  ++ +  -- 
Xanthomonas campestris pv 
musacearum 
Uganda 4383  ++  ++  ++ +  -- 
Xanthomonas campestris pv 
musacearum 
DR Congo 4387  ++  ++  ++ +  -- 
Xanthomonas campestris pv 
musacearum 
Rwanda 4389  ++  ++  ++ +  -- 
Xanthomonas campestris pv 
musacearum 
Tanzania 4392  ++  ++  ++ +  -- 
Xanthomonas campestris pv 
musacearum 
Burundi 4433  ++  ++  ++ +  -- 
Xanthomonas campestris pv 
musacearum 
Kenya 4434  ++  ++  ++ +  -- 
[Note: 
++ a strong positive result (two coloured lines; coloured test and control line) 
+ a faint test line only, hence a weak positive 
–a negative result (control coloured line only). 
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The strains in green were expected to give positive results (the LFD was supposed to 
detect the strain), while the strains in red were expected to give a negative result (one 
coloured line) but instead gave positive result.] 
 
4.3 Pathogenicity trials 
To further support the introduction of a new pathovar Xanthomonas vasicola pv 
musacearum to the Xanthomonas vasicola species, there was need for substantial data 
on the comparative pathogenicity of the Xanthomonas vasicola pathovars. The 
pathogenicity trials began with pilot trials to determine how much of the bacteria was 
needed to cause virulence within the plants and what symptoms were expected to be 
seen on the inoculated plants. In the pilot trials, maize, sorghum and banana plants 
were inoculated with Xcm, Xvv, and Xvh, and Xav on maize and banana. These strains 
were assumed to be pathogenic to some of the plants. In the large scale trial, other 
common plant pathogenic Xanthomonas pathovars and non-Xanthomonas strains were 
included to be able to bring out the distinct pathogenicity of the Xv pathovars and Xcm 
on maize, banana and sugarcane. 
 
4.3.1 Pilot trials 
About 200µl to 300µl of bacterial inoculum at 107 cfu/ml was enough to cause virulence 
in maize and banana. All control plants; untreated and those inoculated with sterile 
water remained healthy.  
 
4.3.1a Pilot trial of pathogenicity on banana 
Symptoms on banana appeared 3-week after inoculation for both the Cavendish and 
Tropicana banana plants that had been inoculated with Xcm (NCPPB 4392 and NCPPB 
2005) developed necrotic leaf symptoms, wilting and eventually the whole plant rotted 
by the end of the trial (5-weeks). The banana plants (of both varieties) that were 
inoculated with the Xvh (NCPPB 1060) had no visible symptoms and remained healthy 
for the duration of the pilot trial (5-weeks).  
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Figure 15: Tropicana bananas 
that had been inoculated with 
Xvh NCPPB 1060 (front 
centre), with Xcm NCPPB 
4392 & NCPPB 2005 (back) 
and the controls (left side) 5-
weeks after inoculation the 
banana pilot pathogenicity 
trial. 
[Note: The four plants that had 
been inoculated with Xcm are 
wilted and necrotic.] 
 
 
 
Figure 16: Cavendish dwarfs 
bananas inoculated with Xvh 
NCPPB 1060 (middle), Xcm 
NCPPB 2005, NCPPB 4392 
(left side) and the controls 
(right side) 5-weeks after 
inoculation pilot 
pathogenicity trial. 
[Note: The three plants that had 
been inoculated with Xcm are 
wilted and necrotic.] 
 
 
4.3.1b Pilot trial of pathogenicity on maize 
Symptoms on maize appeared 1-week after inoculation for the plants that had been 
inoculated with Xv pathovars and Xav strains. Symptoms exhibited included leaf 
chlorosis, yellow-brown or water soaked streaks or brown lesions on the leaves, usually 
beginning in the centre of the leaf. The most severe symptoms included deformation of 
the plant and retarded growth by Xvv (NCPPB 702, NCPPB 795) and Xvh (NCPPB 
1060), respectively. Out of the 8 maize plants inoculated with Xcm (NCPPB 4434, 
NCPPB 4378), only one plant (inoculated with Xcm NCPPB 4378) showed identical 
symptoms, but not as virulent as those seen on plants inoculated with Xvv and Xvh, the 
leaves only had yellow-brown streaks. Sedum plants did not show any symptoms and 
were therefore not used for the rest of the pathogenicity trial.  
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Figure 17: Untreated 
maize control plants 
used in the pilot 
pathogenicity trial and 
(left) the sedum plant 
used as a plant 
indicator; 1-week into 
the trial 
 
 
Figure 18: Maize (left) 
and sedum (right) 
control plants that had 
been inoculated with 
sterile water;1-week 
after inoculation 
 
 
Figure 19: Brown 
lesions leaf symptoms 
of maize inoculated 
with Xvv NCPPB 702 
and NCPPB 795; 1-week 
after inoculation 
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Figure 20: White streak 
lesions leaf symptoms 
of maize inoculated 
with Xvv NCPPB 702 
and NCPPB 795; 1-week 
after inoculation 
 
Figure 21: Yellow streak 
lesions leaf symptoms 
of maize inoculated 
with Xvh NCPPB 1060; 
1-week after inoculation 
 
Figure 22: Deformation 
leaf symptoms of maize 
inoculated with Xvv 
NCPPB 702 and 795; 1-
week after inoculation 
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Figure 23: Water soaked 
leaf symptoms of maize 
inoculated with Xvh 
NCPPB 1060; 1-week 
after inoculation 
 
Figure 24: Stunted 
growth symptoms of 
maize inoculated with 
Xvh NCPPB 1060; 1-
week after inoculation 
 
Figure 25: White streak 
leaf symptom of maize 
inoculated with Xav 
NCPPB 796 and NCPPB 
899; 1-week after 
inoculation 
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Figure 26: Yellow streak 
leaf symptom of maize 
inoculated with Xcm 
NCPPB 4434; 3-weeks 
after inoculation 
 
4.3.1c Pilot trial of pathogenicity on sorghum 
Unexpectedly, all sorghum plants remained healthy including those inoculated with the 
strains of Xvh that is a known host of this pathovar. However an ICRISAT report on 
Bacterial leaf streak of sorghum in India (Navi et al, 2002), also reported unsuccessful 
attempts at artificially inoculating sorghum seedlings. They concluded that Xvh strains 
could only be isolated from already naturally infected plants. 
 
4.3.1d Sugarcane pilot trial 
Unfortunately multiplication of sugarcane plants was slow and we were unable to obtain 
enough sugarcane plantlets in time for a pilot trial. Therefore the decision was made to 
maintain the available plants for the full trial only. 
 
4.3.2 Full-scale pathogenicity trial 
In the full-scale pathogenicity trial for maize, banana and sugarcane, plants were not 
only inoculated with the Xv pathovars (Xvv, Xvh, and Xcm) but also plant pathogenic 
Xanthomonas pathovars: X. campestris pv campestris and X. campestris pv vesicatoria 
etc and some non-Xanthomonas species, Paenibacillus larvae. The evaluation of this 
broader set of strains was to bring out the distinct pathogenicity of the Xv pathovars on 
maize, banana and sugarcane. The trial had at least 3 plants inoculated with one 
pathovar thereby eliminating or minimizing bias and errors due to inoculation.  
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4.3.2a Viability of bacteria 
The viability of the bacterial suspensions used as inoculums was proven; all showed 
growth on solid media YDC after incubation at 25ºC for 48 hours. 
 
4.3.2b Re-isolation of bacteria from plants 
In most cases bacteria were successfully re-isolated after at least 5 – 7 weeks from 
inoculated plants; especially for Xcm and Xvv inoculated plants. Confirmation of identity 
for Xcm and Xvv strains was achieved by PCR using the primers GspDmFR (Adriko et 
al, 2011) and XW1F/R (Lewis-Ivey et al, 2010), respectively. For Xanthomonas 
campestris pv campestris, and X. campestris pv pelargonii where bacterial colonies 
consistent with a Xanthomonas morphology were recovered this was considered 
diasgnostic for the species. The non-Xanthomonas strain of Paenibacillus larvae were 
not recovered at the end of all the trials (usually 7-weeks long). 
 
4.3.2c Full-scale pathogenicity trial of Xanthomonas strains on banana 
All banana plants inoculated with Xcm strains showed severe symptoms typical of 
Xanthomonas Wilt. From these plants Xcm was readily re-isolated.  All plants inoculated 
with the Xv pathovars (Xvv and Xvh) remained healthy, although re-isolation of these 
strains was successful. Plants that were inoculated with Xanthomonas arboricola pv 
celebensis (Xac) and Xanthomonas species (NCPPB 1131 and 1132), that had been 
originally isolated from banana, remained healthy and re-isolation of the bacteria was 
unsuccessful. All banana plants in the trial including the controls (untreated and those 
inoculated with sterile water) had their older leaves yellowing, with scorched 
appearance. This was attributed to natural ageing rather than inoculation.  
 
Plants inoculated with Xcm showed severe symptoms of XW as described by Yirgou 
and Brabury (1974) 3-weeks after inoculation (see Figures 27-29). The disease affected 
the younger leaves first, beginning with dull green colouring of the lamina, folding of the 
two halves of the midrib until touching each other, yellowing of the leaves, reddish 
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brown streaks on the leaf, eventually all the leaves wilted and the entire plant rotted. 
Most of the Xcm inoculated plants were dead by the 7th week of the trial.  
 
Symptom severity was scored as follows:  
 0 – no visible symptoms 
 1 – slight wilting/folding of lower leaves 
 2 – pronounced wilting/yellowing of most leaves 
 3 – pronounced necrosis of the whole plant 
 4 – complete death, rotting of the plant 
 
Some Xcm-inoculated plants remained healthy and re-isolation of the bacteria from 
these plants was unsuccessful. Re-isolation of the Xcm from most Xcm-inoculated 
plants was successful, but difficult from plants that had already died and had been 
colonised by faster growing saprophytic microbial organisms that outcompeted Xcm on 
the YDC media plate. Other pathovars (X. axonopodis pv vasculorum, X. campestris pv 
pelagonii (NCPPB 2985, NCPPB 4031), X.campestris pv campestris (NCPPB 529) and 
X. campestris pv vesicatoria (NCPPB 422, NCPPB 701)) did not cause disease in 
bananas but were successfully re-isolated. This suggests that banana can be a host to 
other significant Xanthomonas plant pathogens other than Xcm, Xvv and Xvh. Non-
Xanthomonas strain, Paenibacillus larvae was not successfully re-isolated. 
 
Figure 27: Large scale 
banana pathogenicity 
trial 
[Note: The trial was 
randomized, that is plants 
with similar treatments 
were not adjacent.] 
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Figure 28: XW symptom score 1; pale colouring of the lamina, folding of the 
leaves along the mid-rib with the two halves touching; 5-weeks after 
inoculation 
  
Figure 29:  XW symptom score 2; yellowing of the leaves and appearance of 
reddish-brown streaks on the leaves; 5-weeks after inoculation 
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Figure 30: XW symptom score 3; wilting of most leaves and entire necrosis 
of the plant; 5-weeks after inoculation 
[Note: For the purposes of the photographs the plants were rearranged by 
treatment, otherwise they were fully randomized during the trial ] 
 
Table 11: Symptom scores for Xcm-inoculated individual banana plants of the 
main pathogen trial:- 0 – no visible symptoms, 1 – Slight wilting/folding of 
younger leaves,2 - Pronounced wilting/yellowing of most leaves,3 – Pronounced 
necrosis of the whole plant ,4 – Complete death, rotting of the whole plant 
Treatment Plant no. Week 1 Week 2 Week 3 Week 4 Week 5 Week 7 
Xcm 
NCPPB 
2005 
1 0 0 0 0 2 2 
2 0 0 1 1 3 4 
3 0 0 1 1 2 3 
4 0 0 0 0 2 2 
Xcm 
NCPPB 
4379 
1 0 0 0 0 0 0 
2 0 0 0 0 0 0 
3 0 1 2 3 4 4 
4 0 0 0 2 2 3 
Xcm 
NCPPB 
4387 
1 0 0 2 2 4 4 
2 0 0 2 2 3 4 
3 0 0 2 2 3 4 
4 0 0 1 2 3 4 
Xcm 
NCPPB 
1 0 0 0 0 0 0 
2 0 0 0 1 1 1 
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4.3.2d Full scale pathogenicity trial of Xanthomonas strains on maize 
Control plants that had been inoculated with sterile water and others left untreated 
remained healthy throughout the trial. Plants inoculated with strains Xvv, Xvh and Xav 
displayed symptoms consistent with the pilot studies (see Figures 32-38). Symptoms 
appeared 6-days after inoculation; these included yellow, brown, white or water soaked 
streaks as well as brown lesions on the leaves, usually beginning in the centre of the 
leaf. The most severe symptoms were deformation of the plant and retarded growth by 
strains of Xvv and Xvh, respectively, revealing distinct pathogenicity of the two strains 
on maize.   
 
Symptoms were scored according to the type of symptom, rather the severity: 
 0 – no visible symptoms 
 1 – water-soaked like streaks 
 2 – yellow or brown or white streaks 
 3- brown lesions 
 4 – deformation of plant or stunted growth 
 
The 28 plants that had been inoculated with Xcm did not exhibit any of the symptoms 
throughout the trial, suggesting that Xcm does not affect maize under these conditions. 
Furthermore, re-isolation from a few of these plants was successful even 5 weeks after 
inoculation suggesting that Xcm can survive in maize without causing any symptoms. 
Plants inoculated with other common plant pathovars; X. campestris pv campestris, X. 
4390 3 0 0 0 1 1 1 
4 0 0 1 3 4 4 
Xcm 
NCPPB 
4433 
1 0 0 0 2 3 3 
2 0 0 0 0 0 0 
3 0 0 2 4 4 4 
4 0 0 0 0 0 1 
Xcm 
NCPPB 
4434 
 
1 0 0 0 1 1 3 
2 0 0 1 2 3 4 
3 0 0 2 2 4 4 
4 0 0 2 2 3 4 
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campestris pv vesicatoria and X. campestris pv pelargonii did not show any signs of 
disease (not re-isolated). 
 
 
Figure 31: Large scale 
maize pathogenicity trial 
(the plant location was 
randomized) 
 
 
Figure 32: The control 
maize plants; untreated 
and those inoculated with 
sterile water in the large 
scale maize pathogenicity 
trial 
 
 
Figure 33: Brown streak 
leaf symptom of maize 
inoculated with Xav 
(NCPPB 796 and NCPPB 
899) 
95 
 
Figure 34: White streak leaf 
symptom of maize; 3-
weeks after inoculation 
with Xav (NCPPB 796 and 
NCPPB 899) 
 
Figure 35: Stunted/ 
deformed growth symptom 
(score 4) of maize; 3-weeks 
after inoculation with Xvh 
(NCPPB 1060) 
 
Figure 36: Brown streak 
leaf symptom (score 3) of 
maize; 3-weeks after 
inoculation with Xvh 
(NCPPB 1060) 
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Figure 37: Stunting/ 
deformation of plant 
symptom (score 4) of 
maize; 3-weeks after 
inoculation with Xvv 
(NCPPB 895, NCPPB 702, 
NCPPB 206, NCPPB 890) 
 
 
Figure 38: Brown streak 
leaf symptom (score 2) of 
maize; 3-weeks after 
inoculation with Xvv 
(NCPPB 895, NCPPB 702, 
NCPPB 206, NCPPB 890) 
 
Figure 39: Maize plants that 
had been inoculated with 
Xcm and remained healthy 
in the pathogenicity trial 
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The leaf symptoms such as streaks and lesions were not exhibited on leaves that had 
inoculation sites only thereby confirming the symptoms were not as a result of 
hypersensitive response. Some of the plants inoculated with Xvv and Xav that had 
earlier had their leaves with lesions and streaks (1 to 2-weeks after inoculation) 
appeared to recover (became healthy), with no more symptoms developing on 
inoculated leaves or on non-inoculated leaves by the 5th week. Of the plants inoculated 
with Xvh (NCPPB 1060 and 3126) only plants inoculated with NCPPB 1060 exhibited 
symptoms. Those inoculated with Xvh NCPPB 3126 remained healthy throughout the 
trial even 1-week after inoculation. However, re-isolation of the Xvh bacteria was 
successful for both strains.  Results are summarised in Table 12. 
 
Table 12: Symptom scores for individual maize plants that had been inoculated 
with Xav, Xvh, Xvv and Xcm in the main maize pathogen trial;1-week after 
inoculation: 0 – no visible symptoms, 1 – Water-soaked streaks, 2 – Yellow brown 
or white streaks, 3 – Brown lesions, 4 – Deformation of plant or stunted growth. 
Treatment Plant no. Week 1 Week2 Week 6 
Xav NCPPB 796 1 1,2 2,3 0 
2 1,2 3 0 
3 1,2 2,3 2 
4 1,2 2 2 
Xav NCPPB 899 1 1 3 0 
2 0 3 2 
3 0 3 2 
4 0 2 2 
Xvh NCPPB1060 1 2 4 2 
2 1 3 2,3 
3 1 1,2 2 
4 1,2 2,3 2,3 
Xvh NCPPB 3162 1 0 0 0 
2 0 0 0 
3 0 0 0 
4 0 0 0 
Xvv NCPPB 895 1 1 2 0 
2 1 1,2 2,3 
3 1,2 2,3 2,3 
4 1 2,3 2,3 
Xvv NCPPB 702 1 1,2,3 2,3 0 
2 1,2 2,3 0 
3 1,2 3 1,2 
4 2 3 0 
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Xvv NCPPB 890 1 1 1,2 0 
2 1,2 2 0 
3 1,2 3 0 
4 1,2 2,3 0 
Xvv NCPPB 206 1 2,4 4 4 
2 1,3 2,3 3 
3 2,3 2,3 2 
4 1 2,4 4 
Xcm NCPPB 4379 1 0 0 0 
2 0 0 0 
3 0 0 0 
4 0 0 0 
Xcm NCPPB 4387 1 0 0 0 
2 0 0 0 
3 0 0 0 
4 0 0 0 
Xcm NCPPB 4390 1 0 0 0 
2 0 0 0 
3 0 0 0 
4 0 0 0 
Xcm NCPPB 2005 1 0 0 0 
2 0 0 0 
3 0 0 0 
4 0 0 0 
Xcm NCPPB 4434 1 0 0 0 
2 0 0 0 
3 0 0 0 
4 0 0 0 
Xcm NCPPB 4433 1 0 0 0 
2 0 0 0 
3 0 0 0 
4 0 0 0 
[Note: All plants inoculated with Xcm remained healthy throughout the trial. Plants 
inoculated with Xav NCPPB796 and NCPPB 899 and Xvv NCPPB 890 and NCPPB 702 
exhibited recovery from initial symptoms] 
 
4.3.2e Full scale pathogenicity trial of Xanthomonas strains on sugarcane 
All control plants; those inoculated with sterile water and the untreated remained healthy 
throughout the trial. X. campestris pv pelargonii, X. campestris pv vesicatoria and the 
Xanthomonas species (NCPPB 1131), caused white lesions around the inoculation site 
99 
on the leaves suspected to be a hypersensitive reaction (HR) to the pathogens in 
sugarcane,1-week after inoculation (see Figure 40).  
 
Xav, Xcm, Xvh and Xvv caused foliar symptoms such as reddish-brown streaks and 
spots. Xcm also caused white and yellow streaks on the leaves. Similarly, the Xav strain 
caused white streaks on the leaves. These symptoms appeared 1-week after 
inoculation. Out of the 6 plants inoculated with Xvh, only those inoculated with NCPPB 
1060 gave symptoms (those inoculated with Xvh NCPPB 3126 remained healthy). Out 
of the 6 plants inoculated with Xav, 2 of them remained health. Out of the 12 plants 
inoculated with Xvv, 2 of them remained health. Out of 21 plants inoculated with Xcm, 7 
remained healthy throughout the trial. All other common plant Xanthomonas pathovars 
as well as Paenibacillus larvae did not affect sugarcane.  
 
As with maize, symptoms were scored according to the type of symptom, rather the 
severity: 
 
 0 – no visible symptoms 
 1- white streaks or lesions 
 2 – reddish-brown streaks or lesions 
 3 – yellow streaks 
 
The results are summarised in Table 13. 
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Figure 40: Main sugarcane full 
scale pathogenicity trial in the 
glasshouse 
 
Figure 41: Left, white 
hypersensitive response 
patches seen about points of 
inoculation on the leaves of 
sugarcane inoculated with 
X.campestris pv pelargonii 
(NCPPB 2985)
inoculation in the main 
sugarcane pathogenicity trial
 
 
Figure 42: Below, reddish/brown 
leaf symptoms caused by Xvv 
(NCPPB 895, NCPPB 206)
week after inoculation in the 
main sugarcane pathogenicity 
trial 
; 1-week after 
 
; 1-
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Figure 43: Left, reddish/brown 
leaf symptoms (score 2) caused 
by Xvh NCPPB 1060; 1-week 
after inoculation in the main 
sugarcane pathogenicity trial 
 
Figure 44: Reddish/brown leaf 
symptoms (score 2) caused by 
Xcm; 1-week after inoculation in 
the main sugarcane 
pathogenicity trial 
 
Figure 45: White streak leaf 
symptoms (score 1) caused by 
Xav (NCPPB 796); 1-week after 
inoculation in the main 
sugarcane pathogenicity trial 
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Figure 46: Reddish/brown leaf 
symptoms (score 2) caused by 
Xav; 1-week after inoculation in 
the main sugarcane 
pathogenicity trial 
 
Table 13: Symptom scores of individual plants inoculated with Xvv, Xvh, Xav and 
Xcm in the main sugarcane pathogen trial: 0 – no visible symptoms, 1- white 
streaks or lesions, 2 – reddish-brown streaks or lesions, 3 – yellow streaks. 
Treatment Plant no. Week 1 Week 2 Week 3 Week 4 
Xav NCPPB 796 1 0 2 2++ 2 
2 0 0 0 0 
3 0 0 0 0 
Xav NCPPB 899 1 2 2++ 2,3++ 2,3 
2 2 2 2,3++ 2,3 
3 0 0 1++ 1 
Xvh NCPPB 1060 1 2 2,3++ 2,3++ 2,3 
2 2,3 2,3++ 2,3++ 2,3 
3 2 2+ 2+ 2 
Xvh NCPPB 3162 1 0 0 0 0 
2 0 0 0 0 
3 0 0 0 0 
Xvv NCPPB 895 1 2 2,3 2,3+++ 2,3 
2 0 0 0 0 
3 2 2 2 2 
Xvv NCPPB 702 1 0 2 2 2 
2 2 2 2,3 2,3 
3 0 2 2 2 
Xvv NCPPB 890 1 0 2 2 2 
2 0 0 0 0 
3 3 2,3 2,3 2,3 
Xvv NCPPB 206 1 2 2 2,3+++ 3 
2 2 2 2,3+++ 2,3 
3 2 2 2++ 2 
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Treatment Plant no. Week 1 Week 2 Week 3 Week 4 
Xcm NCPPB 4379 1 0 0 0 0 
2 0 0 0 0 
3 1 1 0 0 
Xcm NCPPB 4387 1 0 0 0 0 
2 0 0 0 0 
3 1 1,2++ 1,2++ 1,2 
Xcm NCPPB 4390 1 0 0 0 0 
2 0 1 1 1 
3 0 0 0 1 
Xcm NCPPB 2005 1 0 0 0 0 
2 0 0 2+ 2 
3 2 1,2 1,2++ 1,2++ 
Xcm NCPPB 4434 1 2 2+ 2+ 2 
2 0 2+ 2+ 2 
3 2 2+ 2+ 2 
Xcm NCPPB 4433 1 1 1+ 1 1 
2 1 1+ 1 1 
[Note: Xvh NCPPB 3162 did not cause any symptoms on sugarcane plants in the trial, + 
means severe, ++ means very severe] 
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Figure 47: Schematic of host range of Xcm and Xav and Xv pathvars 
 
 
 
 
 
 
 
 
 
 
 
[Note: 
                          Means bacteria strain is consistently pathogenic on host 
                          Means bacteria strain can sometimes be pathogenic on host 
Pathogenicity on sorghum was not successfully demonstrated for any strain under this 
study; however, Xvh is reported in the literature as a pathogen of sorghum and is 
indicated as a pathogen of sorghum] 
 
4.4 Genotyping of X.campestris pv musacearum isolates from Western Uganda 
Previous studies (Aritua et al, 2008, Aritua et al, 2007, Odipio et al, 2009 and Lewis-Ivey 
et al, 2010) that conducted FAME analysis, REP-PCR and ERIC-PCR had shown 
populations of Xcm to be genetically homogenous with very limited genetic variability. 
The assays described above are suitable, with various levels of success, to detect and 
identify Xcm and distinguish between Xcm and its close relatives that are not banana-
pathogens. However recent genome-wide sequence analyses of Xcm have revealed 
some (limited) genetic diversity within Xcm (Wasukira et al, 2012). The study revealed 
that there was genetic variations within Xcm based on Single nucleotide polymorphisms 
(SNPs) and that these 86 SNPs  divided the Xcm populations between two major sub 
lineages (I&II) or genotypes. These two lineages appear, based on a limited number of 
isolates, to be associated with specific geographical locations: lineage I were Xcm 
strains from DR Congo, Rwanda and Ethiopia whilst lineage II are Xcm strains from 
Banana Sugarcane Maize Sorghum 
Xvv Xvh Xcm Xav 
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Uganda, Kenya and Burundi. Primers designed based on these SNPs will distinguish 
between different genotypes of Xcm and may be informative for tracking spread of the 
pathogen over space and time. 
 
A new collection of Xcm strains from Western Uganda were analyzed based on the 
SNPs primers to validate some of the genetic variation reported by Wasukira et al 
(2012) and to explore the genetic diversity within this single geographical region, 
Western Uganda, a region whose Xcm genotypes had not previously been investigated 
and which lies geographically between two regions (Eastern DRC and central Uganda) 
that were genetically distinct from each other. 
 
The SNPs primers amplified the target DNA around the SNPs (at different loci) as 
reported by Wasukira et al (2012) and the 500bp PCR amplicon was digested by 
respective restriction enzymes to detect these SNPs that fell within the restriction sites. 
The four sets of primers( see Table 6) chosen were used to run PCR reactions on the 
Xcm samples and only the reactions from which clear products were got were further 
digested by the specific restriction enzymes. The controls of the PCR digests were three 
Xcm strains: Xcm NCPPB 2005 and Xcm NCPPB 2251 from Ethiopia (Lineage I) and 
Xcm NCPPB 4380 from Uganda (Lineage II). 
 
4.4.1 RsaACHT01000045FR primer PCR and RsaI restriction digestion of Xcm 
isolates from Western Uganda 
The primers RsaACHT01000045FR distinguished between the two sub-lineages 
(lineage I & II) of Xcm populations. Xcm strains in lineage I have the nucleotide G at 
position 32848 while those in lineage II have the nucleotide A in the same position in the 
draft Xcm genome (Wasukira et al, 2012). They amplified the DNA target region around 
the SNPs and the 500bp product was digested by the enzyme RsaI. The RsaI enzyme 
recognizes and digests the restriction site-sequence 5’-GT↑AC-3’ or 3’-CA↑TG-5’. 
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Figure 48:RsaACHT01000045FR PCR amplicons (500bp) of the 
42) from Western Uganda (refer to Table 15), the PCR amplicon was 500bp
[Note: L 36...40 means the next gel wells are sample 36,sample 37,sample 38,sample 
39 till sample 40] 
 
4.4.1a RsaI digest of the products
Refer to Table 15 for summary of the restriction digest results. The PCR digest product 
was 250bp. Xcm isolates 2,
Only one control Xcm (NCPPB 
while both Ethiopian Xcm strains
Not all PCR amplicons were digested, suggesting that the 
Western Ugandan not only include
strains from lineage I and hence share a similar genotype with those from Rwanda, DR 
Congo and Ethiopia. Samples that digested with 
Uganda, Wasukira et al, 2012) 
NCPPB 4380. 
 
Figure 49:  RsaI digests of the isolates from Western Uganda give a 250bp 
product. The PCR digest separates the two major sub
[Note: c1, c2, c3 are the controls 
2005 (Ethiopia, lineage I) and 
 
 12, 15, 16, 17, 67 and 73 were left out in 
4380; from Uganda) was digested by the RsaI enzyme
 (NCPPB 2005 and Xcm NCPPB 2251
Xcm
 Xcm strains from Uganda (lineage II) but also 
Xcm NCPPB 4380 (isolate from 
were assumed to share a similar genotype with 
 
 
-lineages (I &II) of 
Xcm NCPPB 2251(Ethiopia, lineage I), 
Xcm NCPPB 4380 (Uganda, lineage II), respectively, the 
 
Xcm samples (1-
 
this assessment. 
, 
) were included. 
 populations from 
Xcm 
Xcm 
Xcm. 
Xcm NCPPB 
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digest product is 250bp. Only control 
were digested.] 
 
4.4.2 StyACHT01000140FR prim
isolates from Western Uganda
The primers StyIACHT01000140FR also distinguished between the two sub
(lineage I & II) of Xcm populations.
position 2515 and the nucleotide C at position 2530 while those in lineage II have the 
nucleotide C at position 2515 and the nucleotide T at position 2530 in the draft genome 
of Xcm (Wasukira et al, 2012). The StyI enzyme recognizes and digests the restriction 
site-sequence CCT↑AGG or CCA↑TGG) 
from Xcm isolates was amplified around the SNPs. 
 
Figure 50: StyACHT01000140FR PCR amplicons of the new collection of 
isolates from Western Uganda, the PCR amplicon was 500bp (see Table 15 for 
summary of results). 
[Note: L...14, means the next gel wells are the ladder, sample 8,9,10,11,12 till sample 
14 while 15....28,means samples 15,16,17,18,19,20,21,22,23,24,25,26,27 
28.] 
 
4.4.2a StyI digest of the products
Refer to table 15 for summary of the restriction digest results. The product size of the 
digestion was 250bp.Only one control 
by the StyI enzyme further confirmi
Uganda fell within sub lineage I and were of similar genotype as
(Wasukira et al, 2012). Not all 
further confirming that the 
Xcm strains from Uganda (lineage II) but also 
share a similar genotype with those from Rwanda, DR Congo 
Xcm NCPPB 4380 together with other samples 
er PCR and StyI restriction digestion of 
 
 Xcm strains in lineage I have the nucleotide T at 
and CCT↑TGG or CCA↑AGG. The target DNA 
The PCR amplicon
 
 
 
Xcm NCPPB 4380 (from Uganda) was digested 
ng that some of the Xcm populations from Western 
 
PCR amplicons of other Xcm isolates were digested 
Xcm populations from Western Ugandan not only include
Xcm strains from lineage I and hence 
and Ethiopia. 
Xcm 
-lineages 
 was 500bp. 
 
Xcm 
till sample 
Xcm NCPPB 4380 
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Figure 51: StyI digests of the 
StyI, the PCR digest separates the two sub lineages I&II of 
[Note: c1, c2, c3 are the controls 
2005(Ethiopia, lineage I) and 
digest product was 250bp. Only control 
were digested. 1.....11,means the next gel wells are  samples 1,2,3,4,5,6,7,8,9,10 till 
sample 11 while 12...22 means sample 12
 
4.4.3 AluACHT010000 43FR primer PCR and AluI restriction digestion of 
samples from Western Uganda
The primers AluACHT01000043FR distinguished between the two Ethiopian strains 
Xcm NCPPB 2005 and Xcm
Xcm NCPPB 2005 and the nucleotide T in 
C is also found at the same position
NCPPB 4379, 4383, 4384, 4380, 4381
4381, Kenya- NCPPB 4434 and Burundi
target DNA of the Xcm isolates was amplified around the SNPs. The 
500bp and was digested by the enzyme Alul. This enzyme 
sequence AG↑CT or TC↑GA.
 
 
  
 
Xcm isolates from Western Uganda by the enzyme 
Xcm.
Xcm NCPPB 2251(Ethiopia, lineage I), 
Xcm NCPPB 4380 (Uganda, lineage II), respectively, the 
Xcm NCPPB 4380, together with other isolates 
,13,14,15,16,17,18,19,20,21 till sample 22.
 
 NCPPB 2251 at position 10914 with the nucleotide C in 
Xcm NCPPB 2251. However the nucleotide 
 (10914) within the lineage II strains  from Uganda 
, Tanzania- NCPPB 4394, NCPPB 4395, NCPPB 
- NCPPB 4433 (Wasukira 
recognizes and cuts the site 
 
 
 
Xcm NCPPB 
] 
Xcm 
–
et al, 2012). The 
PCR amplicon was 
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Figure 52: AluACHT010000
isolates from Western Uganda, the PCR amplicon was 500bp (see Table 15 for 
summary of results). 
 
4.4.3a AluI digest of the products
The above products were set up for digestion by the restriction enzyme AluI. Of the 
three controls used in the digests,
NCPPB 2005 (Ethiopia, Lineage I) and 
Xcm NCPPB 2005 and Xcm
250bp. This revealed that some of 
similar genotype to the Ethiopian stain 
NCPPB 4380. However not all PCR amplicon
of Xcm populations from Western Uganda may also 
Ethiopian isolate Xcm NCPPB 2251.
 
Figure 53: ALuI digests of the AluACHT0100043FR PCR amplicons
Note: c1, c2, c3 are the controls 
2005(Ethiopia, lineage I) and 
digest product is 250bp. The controls 
together with other samples were digested. 22.....27 means the next gel wells are 
samples 23,24,25,26 till sample 27.
 
 43FR PCR amplicons from the new collection of 
 
 Xcm NCPPB 2215 (Enset Ethiopia, Lineage I), 
Xcm NCPPB 4380 (Uganda, lineage II), only 
 NCPPB 4380 were digested, producing one band of 
Xcm populations within the Western Uganda have 
Xcm NCPPB 2005 and the Ugandan strain 
s were digested also suggesting that some 
share a similar genotype with the 
 
 
Xcm NCPPB 2251(Ethiopia, lineage I), 
Xcm NCPPB 4380(Uganda, lineage II) respectively, the 
Xcm NCPPB 4380 and 
] 
 
Xcm 
Xcm 
Xcm 
 
 
Xcm [NCPPB 
Xcm NCPPB 2005 
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4.4.4 BgCHT01000242FR primer PCR and BgII restriction digestion of 
isolates from Western Uganda
The BgII enzyme also differentiates between the two Ethiopian strains 
NCPPB2005 and Xcm NCPPB 2251 at position 12462 with the nucleotide G in 
NCPPB 2005 and the nucleotide A in 
also found in the same position within the lineage II strains: Uganda 
NCPPB 4383, NCPPB 4384, NCPPB 4380
NCPB 4395, NCPPB 4381, Kenya
et al, 2012)). The target DNA of the 
PCR amplicon was 500bp and was digested by the enzyme BgII.
 
Figure 54: BgACHT01000242FR PCR amplicons from the new collection of 
isolates from Western Uganda, the PCR amplicon was 500bp (see Table 15 for 
summary of results). 
[Note: 29.....L means the next gel wells are samples 30,31,32 till the ladder.]
 
4.4.4a BgII digestion of the 
The products were digested with the restriction enzyme BgII and the product size was 
250bp. Two controls: the Ethiopian strain 
Lineage I) and the Ugandan strain 
the other Ethiopian control 
Xcm populations within Western Uganda share the same genotype as that of the 
Ugandan Xcm NCPPB 4380 and the Ethiopian
products were digested further which suggested that some of the 
 
Xcm NCPPB 2251. However,
, NCPPB 4381, Tanzania
- NCPPB 4434 and Burundi- NCPPB 4433 (Wasukira 
Xcm isolates was amplified around the SNPs. The 
 
 
 
PCR amplicons 
Xcm NCPPB 2005 (isolated from Enset, 
Xcm NCPPB 4380 (lineage II) were digested while 
Xcm NCPPB 2251 was not. This suggests that some of the 
 Xcm strain NCPPB 2005.
Xcm 
Xcm 
Xcm 
 the nucleotide G is 
–NCPPB 4379, 
- NCPPB 4394, 
Xcm 
 
 Not all 
Xcm populations of 
113 
Western Uganda may also share a similar genotype with 
Ethiopia. 
 
 
Figure 55: BgII digests of BgACHT01000242FR PCR amplicons
[Note: c1, c2, c3 are the controls 
2005(Ethiopia, lineage I) and 
digest product is 250bp. The controls 
together with other samples got digested. 22.....32 means the next gel wells are 
samples 23,24,25,26,27,28,29,30,31 till sample 32.]
 
4.4.5 Summary of SNP genotyping of Western Ugandan 
Table 15 summaries the results of the genotypin
Uganda based on the SNP primers used. Out of the 86 SNPs that distinguish between 
lineage I and II (Wasukira 
isolates (from the three districts; Bushenyi, Kabale and 
consist of strains that fall either within the sub
revealed isolates that were new recombinants between lineage I and II. The presence of 
new recombinants suggests that the two sub
long time. Those that fall within sub
more genetically similar to the Ugandan strain 
Kampala district, central region). However
also share similar SNP positions with the Ethiopian strain 
from enset in Ethiopia. The samples within sub
the Ethiopian strain Xcm NCPPB 2251
4378, and Rwanda NCPPB 4387). There is evidence of DNA recombination between 
Xcm strains from sub-lineage I and sub
Xcm 
 
 
Xcm NCPPB 2251(Ethiopia, lineage I), 
Xcm NCPPB 4380(Uganda, lineage II) respectively, the 
Xcm NCPPB 4380 and 
 
Xcm samples
g of the Xcm isolates from Western 
et al, 2012), only 2 SNP primers were assayed. The 
Ntungamo in Western Uganda) 
-lineage I and sub
-lineages have been in close proximity for a 
-lineage II consistent with Wasukira 
Xcm NCPPB 4380
, some of these Western Ugandan isolates 
Xcm NCPPB 2005 isolated 
-lineage I have the same genotype as 
 (also similar to those from DR Congo NCPPB 
-lineage II, forming a new ‘hybrid
NCPPB 2251 from 
Xcm NCPPB 
Xcm NCPPB 2005 
 
Xcm 
-lineage II, but also 
et al (2012) are 
 (originally from 
’ genotype; for 
114 
example sample 14 and 54. Both sub-lineages  of Xcm were present in all districts and 
even within a village. 
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5. DISCUSSION 
This study has been able to provide more substantial data on the comparative 
pathogenicity for strains identfied as Xanthomonas vasicola (Xv) pathovars and 
Xanthomonas campestris pv musacearum (Xcm). Strains of Xv pv vasculorum (Xvv) 
and holcicola (Xvh) are able to cause disease in maize and sugarcane through artificial 
inoculation. Even though two pathogens may cause similar symptoms such as lesions 
or streaks on leaves of maize and sugarcane, they caused distinct symptoms in maize: 
Xvv causes deformation of the plant while Xvh causes stunted growth. Unfortunately, 
we were not able to conduct pathogenicity tests on sorghum, to further confirm the 
difference between Xvv and Xvh. The Xv pathovars are divided into two groups 
(Vauterin et al, 1995) holcicola and vasculorum for sorghum and sugarcane 
respectively. Xvv caused deformation/distortion of the plant on maize while Xvh causes 
stunted growth on maize, revealing distinct pathogenicity on the same host. However, 
some of the maize plants that had been affected seemed to recover and showed no 
more signs of disease suggesting that maize may be less susceptible to both 
pathogens. Symptoms caused by both Xv pathovars including Xcm on sugarcane were 
similar, that is reddish-brown streaks or lesions on the leaves. Though one strain of Xvh 
NCPPB 3162 used in all the main pathogenicity trials was successfully re-isolated, it did 
not cause any symptoms in both maize and sugarcane. This may be an indication that 
there could also be variation in virulence among strains within this pathovar and that 
under some circumstances some strains can act as endophytes. The study has also 
shown Xv pathovars to be non-pathogenic on banana, but able to survive within the 
plant asymptomatically. This suggests banana can be a host to other Xanthomonas 
strains (apart from Xcm) including Xvv and Xvh strains. Xvv and Xvh showed distinct 
pathogenicity on maize: Xvv caused deformation of the plant while Xvh causes stunted 
growth. X. axonopodis pv vasculorum (Xav) is a pathovar that though does not fall 
within the X. vasicola species, but causes similar symptoms (apart from deformation 
and stunted growth) on maize and sugarcane. It was demonstrated that Xav is 
pathogenic on maize and sugarcane, but not banana. This suggests that Xav may share 
a few genetic similarities with the X. vasicola pathovars in terms of its ability to cause 
disease both in maize and sugarcane. 
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Previous studies have shown Xcm to be able to cause disease in maize (Aritua et al, 
2008)but these findings have been weakly supported in our study. Possible reasons as 
to why maize plants in the main trial that had been inoculated with Xcm remained 
healthy include differences in maize cultivars, growth stage or growth conditions of the 
two trials.  The ability of a pathogen to cause disease at one time and not another 
usually occurs due to changes in the host that alters the host-microbe interaction. This 
suggests that most likely the conditions of the green house or the maize varieties used 
in both studies were critical factors. However, as seen from the pathogenicity trials 
where by the maize plants and some banana plants inoculated with Xcm remained 
healthy further supports that fact  that at times disease is the exception rather than the 
rule (Guest and Brown, 1997). It is not always clear cut that disease will depend on the 
resistance or susceptibility of the host plant. The host-parasite-environment interaction 
may be mediated by other complex interchange of signals (Guest and Brown, 1997).  
 
The successful re-isolation of Xcm from the healthy maize plants also further suggests 
that maize can be a reservoir for Xcm strains. This is highly significant and should 
contribute to the control methods of Xanthomonas wilt (XW) of bananas especially since 
maize are among the crops that usually intercropped with bananas in Uganda. Xcm was 
also clearly pathogenic on sugarcane and the symptoms on sugarcane were very 
similar to those caused by the Xv pathovars. Only Xcm was distinctly pathogenic on 
banana while the Xv pathovars did not affect banana. The probable cause for the 
healthy Xcm-inoculated banana plants may have been due to an inoculation error or low 
concentrations of the bacteria in the inoculums. Xanthomonas species NCPPB 1131 
and 1132 originally isolated from bananas (Studholme et al, 2011) were shown to be 
non-pathogenic on banana. Previous studies (Aritua et al, 2008, Parkinson et al, 2009) 
have shown Xcm to fall within the Xv species and the pathogenicity trials have revealed 
that there are clearly interspecific pathovar differences within the species. Of all the 
pathovars, Xvv is the most virulent and it is therefore significant that it is not pathogenic 
on banana. The pathogenicity trials support the hypothesis that Xcm is distinct from 
Xvv. 
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The ELISA polyclonal antibody assay, formatted into an LFD,  was able to detect Xcm. 
However, it cross-reacted with Xav, the strain that causes Gumming disease in 
sugarcane. Xav may not be a significant strain in this study but it causes similar 
symptoms of leaf lesions and streaks as the Xv pathovars as seen in the pathogenicity 
trials. Though DNA-DNA homology studies and B-gyrase analysis have shown this 
strain to belong to the X. axonopodis species, it may share most of its virulence proteins 
with Xvv and Xcm. This hypothesis is supported by the fact that Xav was not only 
pathogenic on sugarcane but also maize consistent with Xv pathovars. Furthermore, 
XW PCR primers (Adikini et al, 2011) that were designed from intergenic regions of 
Xcm also amplified DNA templates from Xav strains. 
 
The ELISA cross-reaction also confirms that Xcm and Xav may be sharing distinctive 
proteins that are  not conserved in Xvv. To test this hypothesis we ran a protein blast on 
the NCBI website between Xcm NCPPB 4381, Xav NCPPB 702 and X.axonopodis pv 
citri (the closest available whole genome to Xav). However, the percentage similarity 
between Xcm and Xvv or Xcm and X.axonopodis pv citri was at least 95% and this 
made it difficult to pinpoint which proteins may be differentiating.  
 
The cross-reaction may also be due to the fact that the lipo-polysaccharide locus in Xcm 
closely matches that of Xanthomonas axonopodis (93% nucleotide sequence identity; 
Studholme et al, 2010).  Although lipo-polysaccharides are not proteins, theoretically the 
polyclonal antibodies could interact with the cell walls (made of lipo-polysaccharides) of 
the antigen (live bacteria) first.  
 
This cross-reaction of the polyclonal, formatted for ELISA or LFDs, does not lessen the 
usefulness of the diagnostic as Xav is not a known pathogen on banana and therefore 
unlikely to be found in banana at high concentrations. IITA’s polyclonal antibody for 
Xanthomonas wilt of bananas not only cross-reacted with Xav but with Ralstonia 
solanacearum and Xanthomonas arboricola pv celebensis. This also implies that some 
proteins in Xcm may be similar to those in R. solanacearum and Xanthomonas 
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arboricola pv celebensis. We blasted proteins from R. solanacearum Po82, one of the 
available genomes on the NCBI website against Xcm NCPPB 4381 to determine any 
proteins shared. Only few proteins (such as putative secreted proteins 44% or 
phusphoglycosamine mutase 52%) were similar between the two strains but were less 
than 55% similar, which does not sufficiently explain why the IITA’s XW polyclonal 
cross-reacted with R. solanacearum. Potentially the cross-reactivity associated with the 
IITA polyclonal may present a diagnostic constraint as both R. solanacearum and Xac 
are pathogens of banana. 
 
The LFD was able to detect bacteria at concentrations as low as 104 cfu/ml. It can be 
assumed that an infected banana plants (most likely the East African Highland 
bananas) in Uganda will tend to have more than 1010 cfu/ml concentration of bacteria 
and therefore be easily detected.  
 
Under this study the most effective PCR diagnostic assays for detecting Xcm was 
shown to be the GspDmFR and NZO85FR primers from Adriko et al (2011) and 
XW1F/3R primers from Lewi-Ivey et al (2010). Despite the fact that they (apart from 
GspDmFR), hybridize DNA templates from the closely related Xvv they still can be 
effective tools for confirming Xcm as the Xv pathovars are not pathogenic on bananas 
and any positive amplification can therefore be assumed to be Xcm. With whole 
genome wide sequencing studies on X.campestris pv musacearum and Xvv, it is now 
possible to design more specific primers for Xcm (Wasukira et al, 2012). 
 
SNP analysis of the Western Ugandan Xcm isolates revealed multiple genotypes within 
the samples. Most of the samples fall within the sub-lineage II and have the same 
genotype as Xcm NCPPB 4380 originally from Kampala (Central region of Uganda, 
where XW of banana was first reported in 2001). This suggests that there may be 
‘movement’ of these strains from the Central region where Xcm was first reported in 
2001 to the Western part of the country. The districts of Kabale and Ntungamo are also 
close to the borders of Rwanda and DR Congo making it possible that Western Uganda 
isolates within sub-lineage I could have been carried into Uganda across the two 
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borders perhaps through already infected suckers or pla
56). 
 
Figure 56: Google Map showing the towns from which the Western Ugandan 
samples came from and their close proximity to Kampala (Central region), DR 
Congo (DRC) and Rwanda
[Note: The red dots are some of the sub
Nyabubare, Maziba, Nyabihoko, Kigarama from which the Western Uganda sample
were isolated.] 
 
SNP genotyping of these isolates also revealed new ‘hybrid’ genotypes between 
bacteria under sub-lineage I and bacteria under sub
recombination, suggesting that these two sub
a long period of time. 
 
nt material (see map in Figure 
 
-counties (left side) (Kaharo, Bwongyera, 
-lineage II most probably through 
-lineages have been in close 
 
Xcm 
s 
proximity for 
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6. CONCLUSION AND FUTURE WORK 
The pathogenicity trials have added substantial data to the comparative pathogenicity 
studies of the Xv pathovars which due may be sufficient to reassign Xcm to X.vasicola 
pv musacearum. However, the failure under this study to cause disease on sorghum 
may yet still frustrate this change. Pathogenicity tests of the Xv pathovars on sorghum is 
important to further confirm the difference between Xvv and Xvh. Genome wide 
sequencing of Xav would reveal the relationship between Xav and the Xv pathovars. It 
would be significant as well to isolate Xanthomonas strains from naturally growing 
maize in the fields to determine if Xcm naturally resides in maize as well. 
 
The development of the LFDs based on the ELISA polyclonal antibody should be able 
to help plant inspectors contain the spread of Xcm pathogen across borders through its 
early detection as an on-site field tool. To complement the polyclonal diganostics, 
especially the LFD, Fera is developing a LAMP assay for Xcm, designing primers from 
the gene sequence of the general secretion pathway D (GspD) of Xcm (Adriko et al, 
2011). This will work hand in hand with the LFD to confirm presence of the pathogen 
through PCR- based and antibody based systems.  
 
Further SNP analysis of more isolates from other countries such as DR Congo and 
Ethiopia (as the probable centre of origin for Xcm) will continue to establish more 
genotypes of Xcm, which in turn would assist in determining the patterns of spread of 
the pathogen within the different regions of East Africa.  Such knowledge will motivate 
new methods of possible containment and control of the pathogen. 
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7. APPENDIX 
Appendix 1: Full Standard protocol for the Plate trapped antigen ELISA assays 
 
1. Prepare dilution of antigen in coating buffer 
2. Coat appropriate number of plates with 100µl per well 
3. Wrap plates in cling film and incubate at 4◦C overnight 
4. Wash plates three times with PBST,250µl per well 
5. Prepare blocking buffer (3% BSA/PBST) and block plates with 200µl per well 
6. Wrap plates with cling film and incubate for 1hour at 33◦C 
7. Wash plates three times with PBST,250µl per well 
8. Dilute control antibody if available in 1:1000 
9. Add antibody to relevant wells,100µl per well 
10. Wrap plates with cling film and incubate for 1hour at 33◦C 
11. Wash plates three times with PBST,250µl per well 
12. Prepare dilution of anti-species polyclonal antibody in dilution buffer (PBST/ 
0.2% BSA) 
13. Add anti-species polyclonal antibody used, 100µl per well 
14. Wrap plates with cling film and incubate for 1hour at 33◦C 
15. Wash plates three times with PBST,250µl per well 
16. Add appropriate substrate 
17. If the anti-species polyclonal antibody used was alkaline Phosphatase 
conjugated, prepare a solution of pNPP at 1mg/ml in substrate buffer 
18.  Add 100µl per well 
19. Incubate in the dark for 1 hour at room temperature 
20. Read plates at 405nm 
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Appendix 2: Full pathogenicity trial plan for banana, maize and sugarcane 
Plant number NCPPB no. Species name 
1 
--- Untreated 
2 
3 
4 
5 
--- Dummy inoculated 
6 
7 
8 
9 
2985 Xanthomonas campestris pv perlagonii 
10 
11 
12 
13 
2198 Xanthomonas arboricola pv celebensis 
14 
15 
16 
17 
796 Xanthomonas axonopodis pv vasculorum 
18 
19 
20 
21 
899 Xanthomonas axonopodis pv vasculorum 
22 
23 
24 
25 
1060 Xanthomonas vasicola pv holcicola 
26 
27 
28 
29 
3129 Xanthomonas vasicola pv holcicola 
30 
31 
32 
33 
895 Xanthomonas vasicola pv holcicola 
34 
35 
36 
37 702 Xanthomonas vasicola pv holcicola 
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Plant number NCPPB no. Species name 
38 
39 
40 
41 
890 Xanthomonas vasicola pv holcicola 
42 
43 
44 
45 
422 Xanthomonas campestris pv vesicatoria 
46 
47 
48 
49 
701 Xanthomonas campestris pv vesicatoria 
50 
51 
52 
53 
4379 Xanthomonas campestris pv musacearum 
54 
55 
56 
57 
4387 Xanthomonas campestris pv musacearum 
58 
59 
60 
61 
4390 Xanthomonas campestris pv musacearum 
62 
63 
64 
65 
206 Xanthomonas vasicola pv vasculorum 
66 
67 
68 
69 
2005 Xanthomonas campestris pv musacearum 
70 
71 
72 
73 
4434 Xanthomonas campestris pv musacearum 
74 
75 
76 
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Plant number NCPPB no. Species name 
77 
4433 Xanthomonas campestris pv musacearum 
78 
79 
80 
81 
529 Xanthomonas campestris pv campestris 
82 
83 
84 
85 
4031 Xanthomonas campestris pv perlargonii 
86 
87 
88 
89 
1131 Xanthomonas spp. 
90 
91 
92 
93 
1132 Xanthomonas spp. 
94 
95 
96 
97 
4393 Xanthomonas spp. 
98 
99 
100 
101 
P Paenibacillus larvae 
102 
103 
104 
105 
--- Untreated 
106 
107 
108 
109 
--- Dummy inoculated 
110 
111 
112 
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Appendix 3: Photos of Lateral Flow Devices showing specificity and sensitivity at 
different concentrations of bacteria 
 
A) Infected leaf sap (left; Xcm 
NCPPB 4434) and healthy leaf 
sap control (right) 
 
 
B) Specificity of the LFD, 2 – 7, 
32 Xcm strains (refer to Table 3) 
 
 
C) Specificity of LFD; 8 – Xvv 
NCPPB 896, 11-Xvh NCPPB 
796, 13-Xav NCPPB 796,15-Xcv 
NCPPB 422,17-Xac NCPPB 
1630,18-Xcc NCPPB 529,19-Xcp 
NCPPB 4031, 41 & 42-
Xanthomonas spp NCPPB 1131 
& 1132, 45 –Ralstonia 
solanacearum NCPPB 3205 
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D) Sensitivity of the LFD with 
Xcm NCPPB 4378 strain in buffer 
A (extraction buffer) at different 
concentrations left to right; 107, 
106, 105, 104, 103 cfu/ml 
 
 
E) Sensitivity of the LFD with 
negative strain Xvh NCPPB 3162 
in buffer A(extraction buffer) at 
different dilutions, left to right; 
107, 106, 105, 104, 103 cfu/ml  
 
F) Sensitivity of the LFD with 
Xcm NCPPB 4433 strain in 
crushed leaf extract at different 
dilutions left to right; 108, 107, 
106, 105, 104, 103  cfu/ml  
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G) Sensitivity of the LFD with 
Xcm NCPPB 4389 in banana sap 
at different dilutions, left to right; 
108, 107, 106, 105, 104, 103, 102  
cfu/ml 
 
 
H) Sensitivity of the LFD with 
Xcm NCPPB 4387 in banana sap 
at different dilutions, left to right; 
108, 107, 106, 105, 104  cfu/ml  
 
I) Sensitivity of the LFD with Xcm 
NCPPB 4392 in banana sap at 
different dilutions, left to right; 
108, 107, 106, 105, 104  cfu/ml 
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J) Sensitivity of the LFD with Xcm 
NCPPB 4434 in banana sap at 
different dilutions, left to right; 
108, 107, 106, 105, 104  cfu/ml  
 
 
K) Sensitivity of the LFD with 
Xcm NCPPB 4433 in banana sap 
at different dilutions, left to right; 
108, 107, 106, 105, 104, 103  cfu/ml 
 
L) Sensitivity of the LFD with Xav 
NCPPB 796 in banana sap at 
different dilutions, left to right; 
108, 107, 106, 105, 104 cfu/ml 
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M) Sensitivity of the LFD with 
Xcm NCPPB 2251 in banana 
sap at different dilutions, left to 
right; 108, 107, 106, 105, 104 
cfu/ml  
 
 
N) Sensitivity of the LFD with 
Xcm NCPPB 4383 in banana 
sap at different dilutions, left to 
right; 108, 107, 106, 105, 104 
cfu/ml  
 
 
 
 
 
  
132 
Appendix 4: PCR results of 
and other bacteria strains from NCPPB
  
XW1F/3R on X.campestris pv musacearum
 
 
 
Lane NCPPB Strain
1 2005 Xcm
2 4392 Xcm
3 4380 Xcm
4 4381 Xcm
5 4383 Xcm
6 4387 Xcm
7 4388 Xcm
8 4390 Xcm
9 4393 Xcm
10 6235 Xcm
11 Water  
 
 
Lane NCPPB Strain
1 4102 Xvh
2 4459 Xcv
3 4379 Xcm
4 4391 Xcm
5 4394 Xcm
6 5898 Xcm
7 6235 Xcm
8 water  
 
 
Lane NCPPB Strain
1 8022 Xac
2 8023 R. solanacearum
3 8024 R. solanacearum
4 8025 R. solanacearum
5 8026 R. solanacearum
6 8027 R. solanacearum
7 8028 P. 
marginalis
8 8029 Enterobacter 
9 8030 S.
10  Healthy banana DNA
11 5959 Xcm
12 Water  
 strains 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
marginalis pv 
 
sp. 
 marcescens 
 
 (+ve control) 
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Appendix 5: PCR results of 
Xcm47FR, and Xcm48FR primers (Adikini 
musacearum strains and other bacteria strains from NCPPB
Primers Xcm12FR 
  
Xcm12FR, Xcm35FR, Xcm36FR, Xcm
et al, 2010) on X.campestris
 
 
Lane NCPPB Strain
1 2005 Xcm
2 4392 Xcm
3 4380 Xcm
4 4381 Xcm
5 4383 Xcm
6 4387 Xcm
7 4388 Xcm
8 4390 Xcm
9 4393 Xcm
10 6235 Xcm
11 Water  
 
Lane NCPPB Strain
1 4102 Xvh
2 4459 Xcv
3 4379 Xcm
4 4391 Xcm
5 4394 Xcm
6 5898 Xcm
7 6235 Xcm
8 Water  
 
Lane NCPPB Strain
1 8022 Xac
2 8023 R. 
3 8024 R. 
4 8025 R. 
5 8026 R. 
6 8027 R. 
7 8028 P. 
marginalis
8 8029 Enterobacter sp
9 8030 S. marcescens
10  Healthy banana
11 5959 Xcm
12   Water  
38FR, Xcm44FR, 
 pv 
 
 
 
 
 
 
 
 
 
 
 (+ve control) 
 
 
 
 
 
 
 
 (+ve control) 
 
 
solanacearum 
solanacearum 
solanacearum 
solanacearum 
solanacearum 
marginalis pv 
 
. 
 
 
 (+ve control) 
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Primers Xcm35FR (Adikini et al, 2010)
 
  
 
 
 
Lane NCPPB 
1 2005 Xcm
2 4392 Xcm
3 4380 Xcm
4 4381 Xcm
5 4383 Xcm
6 4387 Xcm
7 4388 Xcm
8 4390 Xcm
9 4393 Xcm
10 6235 Xcm
11 Water 
Lane NCPPB 
 
 
Lane NCPPB 
1 4102 
2 4459 
3 4379 
4 4391 
5 4394 
6 5898 
7 6235 
8 water 
 
 
Lane NCPPB Strain
1 8022 Xac
2 8023 R. solanacearum
3 8024 R. solanacearum
4 8025 R. solanacearum
5 8026 R. solanacearum
6 8027 R. solanacearum
7 8028 P. 
marginalis
8 8029 Enterobacter sp
9 8030 S. marcescens
10  Healthy
11 5959 Xcm
12   water  
Strain 
 
 
 
 
 
 
 
 
 
 (+ve control) 
 
Strain 
strain 
Xvh 
Xcv 
Xcm 
Xcm 
Xcm 
Xcm 
Xcm (+ve control) 
 
 
 
 
 
 
 
 
marginalis pv 
 
 
 
 banana 
 (+ve control) 
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Primers Xcm36FR (Adikini et al, 2010)
 
 
  
 
 
Lane NCPPB Strain
1 2005 Xcm
2 4392 Xcm
3 4380 Xcm
4 4381 Xcm
5 4383 Xcm
6 4387 Xcm
7 4388 Xcm
8 4390 Xcm
9 4393 Xcm
10 6235 Xcm
11 Water  
 
 
Lane NCPPB 
1 4102 
2 4459 
3 4379 
4 4391 
5 4394 
6 5898 
7 6235 
8 Water 
 
Lane NCPPB Strain
1 8022 Xac
2 8023 R
3 8024 R
4 8025 R
5 8026 R
6 8027 R
7 8028 P
marginalis
8 8029 Enterobacter 
9 8030 S
10  Healthy banana
11 5959 Xcm
12   Water  
 
 
 
 
 
 
 
 
 
 
 (+ve control) 
Strain 
Xvh 
Xcv 
Xcm 
Xcm 
Xcm 
Xcm 
Xcm (+ve control) 
 
 
 
.solanacearum 
. solanacearum 
. solanacearum 
. solanacearum 
. solanacearum 
. marginalis pv 
 
sp. 
. marcescens 
 
 (+ve control) 
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Primers 38FR (Adikini et al, 2010)
 
  
 
 
 
Lane NCPPB Strain
1 2005 Xcm 
2 4392 Xcm 
3 4380 Xcm 
4 4381 Xcm 
5 4383 Xcm 
6 4387 Xcm 
7 4388 Xcm 
8 4390 Xcm 
9 4393 Xcm 
10 6235 Xcm (
11 Water  
 
 
Lane NCPPB strain
1 4392 Xcm 
2 4381 Xcm 
3 4388 Xcm 
4 4390 Xcm 
5 4393 Xcm 
6 4102 Xvh 
7 4459 Xcv 
8 4391 Xcm 
9 4394 Xcm 
10 5898 Xvv 
11 6235 Xcm 
12 Water  
 
 
Lane NCPPB Strain
1 8022 Xac 
2 8023 R. solanacearum
3 8024 R. solanacearum
4 8025 R. solanacearum
5 8026 R. solanacearum
6 8027 R. solanacearum
7 8028 P. 
marginalis
8 8029 Enterobacter 
9 8030 S. marcescens
10  Healthy banana
11 5959 Xcm (
12   water  
 
+ve control) 
 
(+ve control) 
 
 
 
 
 
 
marginalis pv 
 
sp 
 
 
+ve control) 
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Primers 44FR ( Adikini et al,
 
  
 2010) 
 
 
Lane NCPPB Strain
1 2005 Xcm 
2 4392 Xcm 
3 4380 Xcm 
4 4381 Xcm 
5 4383 Xcm 
6 4387 Xcm 
7 4388 Xcm 
8 4390 Xcm 
9 4393 Xcm 
10 6235 Xcm(+ve 
11 Water  
Lane NCPPB Strain
 
 
Lane NCPPB Strain
1 4392 Xcm 
2 4380 Xcm 
3 4381 Xcm 
4 4383 Xcm 
5 4102 Xvh 
6 4459 Xcv 
7 4379 Xcm 
8 4391 Xcm 
9 4394 Xcm 
10 5898 Xvv 
11 6235 Xcm 
12 Water  
 
Lane NCPPB Strain
1 8022 Xac 
2 8023 R. solanacearum
3 8024 R. solanacearum
4 8025 R. solanacearum
5 8026 R. solanacearum
6 8027 R. solanacearum
7 8028 P. marginalis 
marginalis
8 8029 Enterobacter 
9 8030 S. marcescens
10  Healthy banana 
11 5959 Xcm (
12 Water  
 
control) 
 
 
(+ve control) 
 
 
 
 
 
 
pv 
 
sp 
 
 
+ve control) 
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Primers 47FR (Adikini et al, 2010)
 
  
 
 
 
Lane NCPPB Strain
1 2005 Xcm
2 4392 Xcm
3 4380 Xcm
4 4381 Xcm
5 4383 Xcm
6 4387 Xcm
7 4388 Xcm
8 4390 Xcm
9 4393 Xcm
10 6235 Xcm
11 Water  
 
 
Lane NCPPB Strain
1 4102 Xvh 
2 4459 Xcv 
3 4379 Xcm
4 4391 Xcm
5 4394 Xcm
6 5898 Xcm
7 6235 Xcm
8 Water  
 
 
Lane NCPPB Strain
1 8022 Xac 
2 8023 R. solanacearum
3 8024 R. solanacearum
4 8025 R. solanacearum
5 8026 R. solanacearum
6 8027 R. solanacearum
7 8028 P. 
marginalis
8 8029 Enterobacter 
9 8030 S. marcescens
10  Healthy banana
11 5959 Xcm
12   Water  
 
 
 
 
 
 
 
 
 
 
 (+ve control) 
 
 
 
 
 
 (+ve control) 
 
 
 
 
 
 
marginalis pv 
 
sp 
 
 
 (+ve control) 
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Primers 48FR (Adikini et al, 2010)
 
 
 
 
 
  
 
 
 
Lane NCPPB Strain
1 2005 Xcm
2 4392 Xcm
3 4380 Xcm
4 4381 Xcm
5 4383 Xcm
6 4387 Xcm
7 4388 Xcm
8 4390 Xcm
9 4393 Xcm
10 6235 Xcm
11 Water  
 
 
Lane NCPPB Strain
1 8022 Xac 
2 8023 R. solanacearum
3 8024 R. solanacearum
4 8025 R. solanacearum
5 8026 R. solanacearum
6 8027 R. solanacearum
7 8028 P. marginalis 
marginalis
8 8029 Enterobacter 
9 8030 S. marcescens
10  Healthy banana 
11 5959 Xcm (
12 Water  
 
 
 
 
 
 
 
 
 
 
 (+ve control) 
 
 
 
 
 
 
pv 
 
sp 
 
 
+ve control) 
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Appendix 6: PCR results of GspDmFR and NZO85FR primers (Adriko 
on X.campestris pv musacearum
GspDmFR 
 
  
 strains and other bacteria strains
 
 
Lane NCPPB Strain 
1 2005 Xcm 
2 4392 Xcm 
3 4380 Xcm 
4 4381 Xcm 
5 4383 Xcm 
6 4387 Xcm 
7 4388 Xcm 
8 4390 Xcm 
9 4393 Xcm 
10 6235 Xcm (+ve
11 Water  
 
Lane NCPPB Strain 
1 4392 Xcm 
2 4380 Xcm 
3 4381 Xcm 
4 4383 Xcm 
5 4102 Xvh 
6 5898 Xvv 
7 4379 Xcm 
8 4394 Xcm 
9 4391 Xcm 
10 5898 Xvv 
11 Water  
12 6235 Xcm (+ve
 
 
Lane NCPPB Strain 
1 8022 Xac 
2 8023 R. solanacearum
3 8024 R. solanacearum
4 8025 R. solanacearum
5 8026 R. solanacearum
6 8027 R. solanacearum
7 8028 
P. marginalis 
marginalis
8 8029 Enterobacter 
9 8030 S. marcescens
10  Healthy banana
11 5959 Xcm (+ve
12   Water  
et al, 2011) 
 
 control) 
 control) 
 
 
 
 
 
pv 
 
sp 
 
 
 control) 
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NZO85FR 
 
  
 
 
Lane NCPPB Strain
1 2005 Xcm
2 4392 Xcm
3 4380 Xcm
4 4381 Xcm
5 4383 Xcm
6 4387 Xcm
7 4388 Xcm
8 4390 Xcm
9 4393 Xcm
10 6235 Xcm
11 Water  
 
 
Lane NCPPB Strain
1 2005 Xcm
2 4392 Xcm
3 4380 Xcm
4 4102 Xvh
5 5898 Xvv
6 4459 Xcv
7 4379 Xcm
8 4394 Xcm
9 4391 Xcm
10 5898 Xvv
11 6235 Xcm
12 Water  
 
Lane NCPPB Strain
1 8022 Xac
2 8023 R. solanacearum
3 8024 R. solanacearum
4 8025 R. solanacearum
5 8026 R. solanacearum
6 8027 R. solanacearum
7 8028 P. 
marginalis
8 8029 Enterobacter sp
9 8030 S. marcescens
10  Healthy banana
11 5959 Xcm
12   Water  
 
 
 
 
 
 
 
 
 
 
 (+ve control) 
 
 
 
 
 
 
 
 
 
 
 
 (+ve control) 
 
 
 
 
 
 
 
marginalis pv 
 
 
 
 
 (+ve control) 
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